Columbus McKinnon (CMCO) 10-Q 1 Feb 23 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2022	Jan. 30, 2023
Cover [Abstract]
Title of 12(b) Security	Common Stock, $0.01 par value per share
Document Transition Report	false
Document Quarterly Report	true
Document Type	10-Q
Entity File Number	001-34362
Document Period End Date	Dec. 31, 2022
Amendment Flag	false
Entity Registrant Name	Columbus McKinnon Corporation
Entity Incorporation, State or Country Code	NY
Entity Central Index Key	0001005229
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Current Fiscal Year End Date	--03-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Tax Identification Number	16-0547600
Entity Address, Address Line One	205 Crosspoint Parkway
Entity Address, City or Town	Buffalo
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14068
Trading Symbol	CMCO
Security Exchange Name	NASDAQ
City Area Code	(716)
Local Phone Number	689-5400
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		28,608,843

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 81,520	$ 115,390
Trade accounts receivable, less allowance for doubtful accounts ($5,313 and $5,717, respectively)	146,909	147,515
Inventories	200,650	172,139
Prepaid expenses and other	34,529	31,545
Total current assets	463,608	466,589
Property, plant, and equipment, net	94,438	97,926
Goodwill	642,430	648,849
Other intangibles, net	367,659	390,788
Marketable securities	10,207	10,294
Deferred Income Tax Assets, Net	1,574	2,313
Other assets	69,516	68,948
Total assets	1,649,432	1,685,707
Current liabilities:
Trade accounts payable	70,603	90,881
Accrued liabilities	104,233	118,187
Current portion of long term debt and finance lease obligations	40,596	40,551
Total current liabilities	215,432	249,619
Term loan and revolver, less current portion	440,916	470,675
Other non current liabilities	182,203	192,610
Total liabilities	838,551	912,904
Shareholders' equity:
Common Stock, Value, Issued	286	285
Treasury Stock, Value	(1,001)	0
Additional paid in capital	512,418	506,074
Retained earnings	346,868	316,343
Accumulated other comprehensive loss	(47,690)	(49,899)
Total shareholders' equity	$ 810,881	$ 772,803
Common Stock, Shares, Issued	28,608,331	28,517,333
Common Stock, Shares Authorized	50,000,000	50,000,000
Common Stock, Shares, Outstanding	28,608,331	28,517,333
Total liabilities and shareholders' equity	$ 1,649,432	$ 1,685,707

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - shares	Dec. 31, 2022	Mar. 31, 2022
Common Stock, Shares Authorized	50,000,000	50,000,000
Common Stock, Shares, Issued	28,608,331	28,517,333
Common Stock, Shares, Outstanding	28,608,331	28,517,333

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Retained Earnings - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Revenues [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 230,370	$ 216,088	$ 682,397	$ 653,187
Cost of Goods and Services Sold	148,326	141,031	431,516	422,932
Gross Profit	82,044	75,057	250,881	230,255
Operating Expenses [Abstract]
Selling expenses	25,424	24,468	77,197	72,107
General and administrative expenses	25,143	25,144	68,441	78,495
Research and Development Expense	4,839	3,875	15,429	11,283
Amortization of intangibles	6,459	6,254	19,442	18,648
Operating Expenses	61,865	59,741	180,509	180,533
Income from operations	20,179	15,316	70,372	49,722
Other Income & Expenses [Abstract]
Interest Expense	7,303	4,375	20,274	14,774
Gain (Loss) on Extinguishment of Debt	0	0	0	14,803
Investment (income) loss	(574)	(76)	168	(624)
Foreign currency exchange (gain) loss	(3,359)	512	(1,152)	1,047
Other (income) expense, net	79	(455)	(1,999)	(744)
Income Tax Expense Benefit [Abstract]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	16,730	10,960	53,081	20,466
Income tax expense (benefit)	4,701	1,066	18,547	2,632
Net income (loss)	12,029	9,894	34,534	17,834
Retained Earnings Accumulated Deficit [Abstract]
Retained earnings - beginning of period	336,844	300,036	316,343	293,802
Retained earnings - end of period	$ 346,868	$ 308,223	$ 346,868	$ 308,223
Weighted Average Number Of Shares Outstanding Basic [Abstract]
Average basic shares outstanding	28,626	28,469	28,597	27,887
Weighted Average Number Of Shares Outstanding [Abstract]
Average diluted shares outstanding	28,778	28,840	28,767	28,255
Earnings Per Share Basic [Abstract]
Basic income (loss) per share:	$ 0.42	$ 0.35	$ 1.21	$ 0.64
Earnings Per Share Diluted [Abstract]
Diluted income (loss) per share:	0.42	0.34	1.20	0.63
Common Stock, Dividends, Per Share, Declared	$ 0.07	$ 0.06	$ 0.14	$ 0.12
Retained Earnings
Income Tax Expense Benefit [Abstract]
Net income (loss)	$ 12,029	$ 9,894	$ 34,534	$ 17,834

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 12,029	$ 9,894	$ 34,534	$ 17,834
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	12,272	(2,215)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	1,962	410
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	14,004	(1,654)	2,209	(6,588)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	26,033	8,240	36,743	11,246
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(595)	(136)	(2,833)	824
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	230	(151)
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	73	(52)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent				(93)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax			(26)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	810,881	745,635	810,881	745,635
AOCI Attributable to Parent
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	0	0
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	12,272	(2,215)	(7,210)	(4,365)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	1,962	410	9,337	(2,489)
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	230	(151)	(82)	(266)
Retained Earnings
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	12,029	9,894	$ 34,534	$ 17,834
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	$ 0	$ 0

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ 73	$ (56)	$ (49)	$ (52)	$ (74)	$ 34
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	12,029	14,114		9,894	15,203	(7,263)	$ 34,534	$ 17,834
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	12,272	(10,781)	(8,701)	(2,215)	(4,226)	2,076
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(595)	(1,509)	(812)	(136)	986	(31)	(2,833)	824
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	230	(166)	(146)	(151)	(212)	97
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture					480
Stock Issued During Period, Value, Stock Options Exercised	83	206	415	1,108	1,122	290
Stock-based compensation	3,094		751	2,741		2,262	7,039	8,485
Payments for Repurchase of Common Stock							(1,001)	0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	$ 23	$ 62	$ 1,313	$ 145	$ 147	$ 1,765
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	6,798	31,313	52,276	5,937	32,665	58,081
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	3,258	9,531	18,907	47,292	38,744	12,682			138,000
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	$ 1,962	$ 4,686	$ 2,689	$ 410	$ (2,995)	$ 96
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	810,881	784,384	775,181	745,635	735,158	724,453	810,881	745,635	$ 772,803	$ 530,149
All Other Individuals
Stock-based compensation		2,341			2,762
Director
Stock-based compensation	316	537		240
Retained Earnings
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	12,029	14,114	8,391	9,894	15,203	(7,263)	34,534	17,834
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	0	0	0	0	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	0	0	0	0	0	0
Stock Issued During Period, Value, Stock Options Exercised	0	0	0	0	0	0
Stock-based compensation	0	0	0	0	0	0
Payments for Repurchase of Common Stock							0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	0	0	0	0	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0	0	0	0
Retained Earnings | Director
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture				0	0
Stock-based compensation	0	0
AOCI Attributable to Parent
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	0	0	0	0	0	0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	12,272	(10,781)	(8,701)	(2,215)	(4,226)	2,076	(7,210)	(4,365)
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	230	(166)	(146)	(151)	(212)	97	(82)	(266)
Stock Issued During Period, Value, Stock Options Exercised	0	0	0	0	0	0
Stock-based compensation	0	0	0	0	0	0
Payments for Repurchase of Common Stock							0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	0	0	0	0	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	1,962	4,686	2,689	410	(2,995)	96	9,337	$ (2,489)
AOCI Attributable to Parent | Director
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture				0	0
Stock-based compensation	0	0
Common Stock [Member]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	0	0	0	0	0	0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	0	0	0	0	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	0	0	0	0	0	0
Stock Issued During Period, Value, Stock Options Exercised	0	0	0	1		0
Stock-based compensation	0	0	0	0	0	0
Payments for Repurchase of Common Stock							0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	0	0	(1)	0	0	1
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0	0	0	0
Common Stock [Member] | Director
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture				0	0
Stock-based compensation	0	0
Additional Paid-in Capital [Member]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	0	0	0	0	0	0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	0	0	0	0	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	0	0	0	0	0	0
Stock Issued During Period, Value, Stock Options Exercised	83	206	415	1,107	1,122	290
Stock-based compensation	3,094	2,341	751	2,741	2,762	2,262
Payments for Repurchase of Common Stock							0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	23	62	1,314	145	147	1,766
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0	0	0	$ 0
Additional Paid-in Capital [Member] | Director
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture				$ 240	$ 480
Stock-based compensation	316	537
Treasury Stock
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	0	0	0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	0	0	0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	0	0	0
Stock Issued During Period, Value, Stock Options Exercised	0	0	0
Stock-based compensation	0	0	0
Payments for Repurchase of Common Stock							$ (1,001)
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	0	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	$ 0
Treasury Stock | Director
Stock-based compensation	$ 0	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 34,534	$ 17,834
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Depreciation and amortization	31,380	31,245
Deferred income taxes and related valuation allowance	(783)	(1,940)
Net loss (gain) on sale of real estate, investments and other	347	(390)
Stock-based compensation	7,039	8,485
Amortization of deferred financing costs	1,291	1,274
Gain (Loss) on Extinguishment of Debt	0	(14,803)
Unrealized Gain (Loss) on Derivatives	(598)	682
Gain (Loss) on Disposition of Property Plant Equipment	(232)	(375)
Gain (Loss) on Sale of Assets and Asset Impairment Charges	(175)	0
Other Operating Activities, Cash Flow Statement	5,814	5,936
Changes in operating assets and liabilities, net of effects of business acquisitions:
Trade accounts receivable	(1,401)	3,931
Inventories	(31,701)	(42,215)
Prepaid expenses and other	4,905	(5,544)
Increase (Decrease) in Other Operating Assets	(232)	(298)
Trade accounts payable	(18,756)	(4,229)
Increase (Decrease) in Accrued Liabilities	(7,498)	2,608
Increase (Decrease) in Other Noncurrent Liabilities	(7,382)	(8,080)
Net cash provided by (used for) operating activities	16,902	23,727
INVESTING ACTIVITIES:
Proceeds from Sale and Maturity of Marketable Securities	2,650	3,441
Payments to Acquire Marketable Securities	(3,121)	(6,357)
Payments to Acquire Property, Plant, and Equipment	(9,511)	(9,506)
Proceeds from Sale of Property, Plant, and Equipment	373	461
Proceeds from Equity Method Investment, Distribution, Return of Capital	313	324
Proceeds from Insurance Settlement, Investing Activities	0	482
Payments to Acquire Businesses, Net of Cash Acquired	(1,616)	(539,778)
Net cash provided by (used for) investing activities	(10,912)	(550,933)
FINANCING ACTIVITIES:
Proceeds from the issuance of common stock	704	2,520
Repayment of debt	(30,402)	(467,725)
Proceeds from Issuance of Long-term Debt	0	725,000
Payments for Repurchase of Common Stock	(1,001)	0
Proceeds from Issuance or Sale of Equity	0	207,000
Stock Issued During Period, Value, Stock Options Exercised	0	(26,184)
Proceeds from Derivative Instrument, Financing Activities	18,422	13,234
Payments for Derivative Instrument, Financing Activities	(17,958)	(13,687)
Payments of Dividends	(6,006)	(4,852)
Other	(1,398)	(2,054)
Net cash provided by (used for) financing activities	(37,639)	433,252
Effect of exchange rate changes on cash	(2,221)	(1,474)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(33,870)	(95,428)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	81,770	106,949
Capital Expenditures Incurred but Not yet Paid	199	161
Supplementary cash flow data:
Interest Paid, Excluding Capitalized Interest, Operating Activities	18,883	12,687
Income taxes paid, net of refunds	18,486	4,367
Restricted Cash	$ 250	$ 250

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Equity Statement - USD ($) $ in Thousands	Total	Director	All Other Individuals	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Director	Common Stock [Member]	Common Stock [Member] Director	Retained Earnings	Retained Earnings Director	AOCI Attributable to Parent	AOCI Attributable to Parent Director	Treasury Stock	Treasury Stock Director
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Value, Issued	$ 240
Additional Paid in Capital, Common Stock	296,093
Retained Earnings (Accumulated Deficit)	293,802
Accumulated Other Comprehensive Income (Loss), Net of Tax	(59,986)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	530,149
Proceeds from Other Equity	198,705			$ 198,662		$ 43		$ 0		$ 0
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ 34
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	58,081
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	12,682
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (7,263)			0		0		(7,263)		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	2,076									2,076
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax				0		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	96			0		0		0		96
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	(97)			0		0		0		(97)
Stock Issued During Period, Value, Stock Options Exercised	290			290		0		0		0
Stock-based compensation	2,262			2,262		0		0		0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(1,765)			(1,766)		(1)		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(31)
Proceeds from Other Equity	198,705
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 17,834							17,834
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax										(4,365)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax										(2,489)
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent										266
Stock Issued During Period, Shares, New Issues	4,312,500
Stock-based compensation	$ 8,485
Payments for Repurchase of Common Stock	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	$ 824
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	138,000
Common Stock, Value, Issued	$ 284
Additional Paid in Capital, Common Stock	495,541
Retained Earnings (Accumulated Deficit)	286,539
Accumulated Other Comprehensive Income (Loss), Net of Tax	(57,911)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	724,453
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ (74)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	32,665
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	38,744
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 15,203			0		0		15,203		0
Stock Issued During Period, Value, Stock Dividend	(1,706)			0		0		(1,706)		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(4,226)			0		0		0		(4,226)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(2,995)			0		0		0		(2,995)
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	212			0		0		0		212
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	480				$ 480		$ 0		$ 0		$ 0
Stock Issued During Period, Value, Stock Options Exercised	1,122			1,122				0		0
Stock-based compensation			$ 2,762	2,762		0		0		0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(147)			(147)		0		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	986
Common Stock, Value, Issued	284
Additional Paid in Capital, Common Stock	499,758
Retained Earnings (Accumulated Deficit)	300,036
Accumulated Other Comprehensive Income (Loss), Net of Tax	(64,920)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	735,158
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ (52)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	5,937
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	47,292
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 9,894			0		0		9,894		0
Stock Issued During Period, Value, Stock Dividend	(1,707)			0		0		(1,707)		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(2,215)			0		0		0		(2,215)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	410			0		0		0		410
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	151			0		0		0		151
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture					240		0		0		0
Stock Issued During Period, Value, Stock Options Exercised	1,108			1,107		1		0		0
Stock-based compensation	2,741	$ 240		2,741		0		0		0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(145)			(145)		0		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(136)
Common Stock, Value, Issued	285
Additional Paid in Capital, Common Stock	503,701
Retained Earnings (Accumulated Deficit)	308,223
Accumulated Other Comprehensive Income (Loss), Net of Tax	(66,574)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	745,635
Common Stock, Value, Issued	285
Additional Paid in Capital, Common Stock	506,074
Retained Earnings (Accumulated Deficit)	316,343
Accumulated Other Comprehensive Income (Loss), Net of Tax	(49,899)									(49,899)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	772,803
Treasury Stock, Value	0
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ (49)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	52,276
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	18,907
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest				0		0		8,391		0		$ 0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$ (8,701)			0		0		0		(8,701)		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	2,689			0		0		0		2,689		0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	146			0		0		0		146		0
Stock Issued During Period, Value, Stock Options Exercised	415			415		0		0		0		0
Stock-based compensation	751			751		0		0		0		0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(1,313)			(1,314)		1		0		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(812)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	34,534							34,534
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax										(7,210)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax										9,337
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent										82
Stock-based compensation	7,039
Payments for Repurchase of Common Stock	(1,001)			0		0		0		0		(1,001)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(2,833)
Common Stock, Value, Issued				286
Additional Paid in Capital, Common Stock				505,926
Retained Earnings (Accumulated Deficit)								324,734
Accumulated Other Comprehensive Income (Loss), Net of Tax										(55,765)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	775,181
Treasury Stock, Value												0
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ (56)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	31,313
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	9,531
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 14,114			0		0		14,114		0		0
Stock Issued During Period, Value, Stock Dividend	(2,004)			0		0		(2,004)		0		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(10,781)			0		0		0		(10,781)		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	4,686			0		0		0		4,686		0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	166			0		0		0		166		0
Stock Issued During Period, Value, Stock Options Exercised	206			206		0		0		0		0
Stock-based compensation		537	$ 2,341	2,341	537	0	0	0	0	0	0	0	$ 0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(62)			(62)		0		0		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(1,509)
Common Stock, Value, Issued	286
Additional Paid in Capital, Common Stock	508,948
Retained Earnings (Accumulated Deficit)	336,844
Accumulated Other Comprehensive Income (Loss), Net of Tax	(61,694)									(61,694)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	784,384
Treasury Stock, Value												0
Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, before Tax	$ 73
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures	6,798
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	3,258
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 12,029			0		0		12,029		0		0
Stock Issued During Period, Value, Stock Dividend	(2,005)			0		0				0		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	12,272			0		0		0		12,272		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	1,962			0		0		0		1,962		0
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent	(230)			0		0		0		(230)		0
Stock Issued During Period, Value, Stock Options Exercised	83			83		0		0		0		0
Stock-based compensation	3,094	$ 316		3,094	$ 316	0	$ 0	0	$ 0	0	$ 0	0	$ 0
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures	(23)			$ (23)		$ 0		$ 0		0		0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(595)
Common Stock, Value, Issued	286
Additional Paid in Capital, Common Stock	512,418
Retained Earnings (Accumulated Deficit)	346,868
Accumulated Other Comprehensive Income (Loss), Net of Tax	(47,690)									$ (47,690)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 810,881
Treasury Stock, Shares	31,085
Treasury Stock, Value	$ 1,001											$ (1,001)

Description of Business

Description of Business	9 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	1. Description of Business The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position of Columbus McKinnon Corporation ("the Company") at December 31, 2022, the results of its operations for the three and nine months ended December 31, 2022 and December 31, 2021, and cash flows for the nine months ended December 31, 2022 and December 31, 2021, have been included. Results for the period ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2023. The balance sheet at March 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Columbus McKinnon Corporation Annual Report on Form 10-K for the fiscal year ended March 31, 2022 (the “2022 10-K”). The Company is a leading worldwide designer, manufacturer, and marketer of intelligent motion solutions that efficiently and ergonomically move, lift, position, and secure materials. Key products include hoists, crane components, precision conveyor systems, accumulation tables, rigging tools, light rail workstations, and digital power and motion control systems. The Company is focused on commercial and industrial applications that require the safety and quality provided by its superior design and engineering know-how.

Business Combinations and Asset

Business Combinations and Asset Acquisitions	9 Months Ended
	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Mergers, Acquisitions and Dispositions Disclosures	2. Acquisitions & Disposals 2022 Acquisitions On April 7, 2021, the Company completed its acquisition of Dorner Mfg. Corp. ("Dorner") for $481,012,000. Dorner, headquartered in Hartland, WI, is a leading automation solutions company providing unique, patented technologies in the design, application, manufacturing and integration of high-precision conveying systems. The acquisition of Dorner accelerated the Company’s shift to intelligent motion and serves as a platform to expand capabilities in advanced, higher technology automation solutions. Dorner is a leading supplier to the life sciences, food processing, and consumer packaged goods markets as well as the faster growing industrial automation and e-commerce sectors. The results of Dorner included in the Company’s consolidated financial statements from the date of acquisition are Net sales and Income from operations of $31,064,000 and $4,157,000, respectively, in the three months ended December 31, 2021 and Net sales and Income from operations of $98,781,000 and $8,481,000, respectively, in the nine months ended December 31, 2021. Dorner's Income from operations in the three and nine months ended December 31, 2021 includes $218,000 in integration related severance costs, which have been included in General and Administrative expenses. Dorner's Income from operations in the nine months ended December 31, 2021 includes acquisition related inventory amortization of $2,981,000, which has been included in Cost of products sold. In addition, the Company incurred acquisition and deal expenses in the amount of $53,000 and $8,739,000 in the three and nine months ended December 31, 2021, respectively, which are included in General and Administrative expenses. These costs were immaterial in the three and nine months ended December 31, 2022. Additionally, the Company also incurred $970,000 in costs related to a transaction bonus that was paid 45 days after the acquisition date to key personnel of which $521,000 has been recorded as part of Cost of products sold, $350,000 has been recorded as part of Selling expenses, $74,000 has been recorded as part of General and administrative expenses, and $25,000 has been recorded as part of Research and development expenses in the nine months ended December 31, 2021. To finance the Dorner acquisition, on April 7, 2021 the Company entered into a $750,000,000 credit facility ("First Lien Facilities") with JPMorgan Chase Bank, N.A. ("JPMorgan Chase Bank"), PNC Capital Markets LLC, and Wells Fargo Securities LLC. The First Lien Facilities consist of a Revolving Facility (the “New Revolving Credit Facility”) in an aggregate amount of $100,000,000 and a $650,000,000 First Lien Term Facility ("Bridge Facility"). Proceeds from the Bridge Facility were used, among other things, to finance the purchase price for the Dorner acquisition, pay related fees, expenses and transaction costs, and refinance the Company's borrowings under its prior Term Loan and Revolver. Refer to Note 9, for further details on the Company's new debt agreement and subsequent equity offering. The purchase price has been allocated to the assets acquired and liabilities assumed as of the date of acquisition. The excess consideration of $287,141,000 has been recorded as goodwill as of March 31, 2022. The identifiable intangible assets acquired include customer relationships of $137,000,000, technology of $45,000,000, and trade names of $8,000,000. The weighted average life of the acquired identifiable intangible assets subject to amortization was estimated at 15 years at the time of acquisition. Approximately $8,000,000 of goodwill arising as a result of the acquisition is deductible for tax purposes. The assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands): Cash $ 8,058 Working Capital 20,218 Property, plant, and equipment, net 26,104 Intangible assets 190,000 Other assets 658 Other liabilities (896) Finance lease liabilities (14,582) Deferred and other taxes, net (35,689) Goodwill 287,141 Total $ 481,012 On December 1, 2021, the Company completed its acquisition of Garvey Corporation ("Garvey") for $67,347,000 including $907,000 in cash acquired, after an adjustment for working capital finalized in fiscal 2023 for $1,616,000, and subject to a $2,000,000 contingent payment that only becomes payable if (a) the EBITDA target set forth in the purchase agreement for Garvey for the twelve-month period commencing on the month immediately following closing is achieved and (b) a specific current executive of Garvey remains employed with Garvey until at least March 31, 2023. During the quarter ended December 31, 2022, the EBITDA target measurement period was completed. Garvey's actual EBITDA for the target measurement period exceeded the projected EBITDA as of the opening balance sheet, resulting in an increase to the originally established contingent consideration. As such, the Company recorded an adjustment for $1,230,000, which increased the contingent consideration liability in the Condensed Consolidated Balance Sheet and General and administrative expenses in the Statement of Operations during the quarter ended December 31, 2022. The Company expects to pay the contingent consideration in fiscal year 2024 from an escrow account established at closing. The Company financed the acquisition by borrowing $75,000,000 utilizing the Accordion feature under its existing Term Loan B, discussed in Note 9. Garvey is a leading accumulation systems solutions company providing unique, patented systems for the automation of production processes whose products complement those of Dorner. The transaction was accounted for using the acquisition method and, accordingly, the results of the acquired business have been included in the Company's results of operations from the acquisition date. As the Company determined that the acquisition is not material to its existing operations, certain disclosures, and including pro forma financial information, have not been included. The Company incurred immaterial acquisition and deal costs in the three and nine months ended December 31, 2022. The purchase price has been allocated to the assets acquired and liabilities assumed as of the date of acquisition. The excess consideration of $40,832,000 has been recorded as goodwill, a decrease of $384,000 from March 31, 2022 relating to an adjustment for the contingent payment of $2,000,000 to reclassify it as part of Prepaid expenses and other assets on the Condensed Consolidated Balance Sheet and an increase of $1,616,000 related to the working capital adjustment. The identifiable intangible assets acquired include customer relationships of $8,200,000, engineered drawings of $4,670,000, trademarks of $3,610,000, patent of $2,440,000, backlog of $2,100,000 and non-compete agreement of $330,000. The weighted average life of the acquired identifiable intangible assets subject to amortization was estimated at 10 years at the time of acquisition. All of the goodwill arising as a result of the acquisition is deductible for tax purposes. The assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands): Cash $ 907 Working Capital 1,709 Property, plant, and equipment, net 3,072 Intangible assets 21,350 Other assets 1,382 Other liabilities (1,905) Goodwill 40,832 Total $ 67,347

Revenue Recognition (Notes)

Revenue Recognition (Notes)	9 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	3. Revenue & Receivables Revenue Recognition: Performance obligations The Company has contracts with customers for standard products and custom engineered products, and determines when and how to recognize revenue for each performance obligation based on the nature and type of contract. Revenue from contracts with customers for standard products is recognized when legal title and significant risk and rewards has transferred to the customer, which is generally at the time of shipment. This is the point in time when control is deemed to transfer to the customer. The Company sells standard products to customers utilizing purchase orders. Payment terms for these types of contracts generally require payment within 30 to 60 days. Each standard product is deemed to be a single performance obligation and the amount of revenue recognized is based on the negotiated price. The transaction price for standard products is based on the price reflected in each purchase order. Sales incentives are offered to customers who purchase standard products and include offers such as volume-based discounts, rebates for priority customers, and discounts for early cash payments. These sales incentives are accounted for as variable consideration included in the transaction price. Accordingly, the Company reduces revenue for these incentives in the period which the sale occurs and is based on the most likely amount method for estimating the amount of consideration the Company expects to receive. These sales incentive estimates are updated each reporting period as additional information becomes available. The Company also sells custom engineered products and services, which are contracts that are typically completed within one quarter but can extend beyond one year in duration. For custom engineered products, the transaction price is based upon the price stated in the contract. Variable consideration has not been identified as a significant component of transaction price for custom engineered products and services. The Company generally recognizes revenue for custom engineered products upon satisfaction of its performance obligation under the contract which typically coincides with project completion which is when the products and services are controlled by the customer. Control is typically achieved at the later of when legal title and significant risk and rewards have transferred to the customer or the customer has accepted the asset. These contracts often require either up front or installment payments. These types of contracts are generally accounted for as one performance obligation as the products and services are not separately identifiable. The promised services (such as inspection, commissioning, and installation) are essential in order for the delivered product to operate as intended on the customer’s site and the services are therefore highly interrelated with product functionality. For most custom engineered products contracts, the Company determined that while there is no alternative use for the custom engineered products, the Company does not have an enforceable right to payment (which must include a reasonable profit margin) for performance completed to date in order to meet the over time revenue recognition criteria. Therefore, revenue is recognized at a point in time (when the contract is complete). For custom engineered products contracts that contain an enforceable right to payment (including reasonable profit margin) the Company satisfies the performance obligation over time and recognizes revenue based on the extent of progress towards completion of the performance obligation. The cost-to-cost measure of progress is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of work performed and transfer of control to the customers. Under the cost-to-cost measure of progress, the extent of progress toward completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenues are recognized proportionally as costs are incurred. Sales and other taxes collected with revenue are excluded from revenue. Shipping and handling costs incurred prior to shipment are considered activities required to fulfill the Company’s promise to transfer goods, and do not qualify as a separate performance obligation. Additionally, the Company offers standard warranties which are typically 12 months in duration for standard products and 24 to 36 months for custom engineered products. These types of warranties are included in the purchase price of the product and are deemed to be assurance-type warranties which are not accounted for as a separate performance obligation. Other performance obligations included in a contract (such as drawings, owner’s manuals, and training services) are immaterial in the context of the contract and are not recognized as a separate performance obligation. For additional information on the Company’s revenue recognition policy refer to the consolidated financial statements included in the 2022 10-K. Reconciliation of contract balances The Company records a contract liability when cash is received prior to recording revenue. Some standard contracts require a down payment while most custom engineered contracts require installment payments. Installment payments for the custom engineered contracts typically require a portion due at inception while the remaining payments are due upon completion of certain performance milestones. For both types of contracts, these contract liabilities, referred to as customer advances, are recorded at the time payment is received and are included in Accrued liabilities on the Condensed Consolidated Balance Sheets. When the related performance obligation is satisfied and revenue is recognized, the contract liability is released into income. The following table illustrates the balance and related activity for customer advances in the nine months ended December 31, 2022 and December 31, 2021 (in thousands): Customer advances (contract liabilities) December 31, 2022 December 31, 2021 March 31, beginning balance $ 22,453 $ 15,373 Additional customer advances received 56,902 26,807 Revenue recognized from customer advances included in beginning of period (22,453) (15,373) Other revenue recognized from customer advances (34,302) (13,087) Customer advances recorded from acquisitions — 14,750 Other (1) (418) (354) December 31, ending balance $ 22,182 $ 28,116 (1) Other includes the impact of foreign currency translation Revenue was recognized prior to the right to invoice the customer which resulted in a contract asset balance in the amount of $2,532,000 and $2,410,000 as of December 31, 2022 and March 31, 2022, respectively. Contract assets are included in Prepaid expenses and other assets on the Condensed Consolidated Balance Sheets. Remaining Performance Obligations As of December 31, 2022, the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) was approximately $11,242,000. We expect to recognize approximately 36% of these sales over the next twelve months. Disaggregated revenue In accordance with FASB ASC Topic 606, the Company is required to disaggregate revenue into categories that depict how economic factors affect the nature, amount, timing and uncertainty of revenue and cash flows. The following table illustrates the disaggregation of revenue by product grouping for the three and nine months ended December 31, 2022 and December 31, 2021 (in thousands): Three Months Ended Nine Months Ended Net Sales by Product Grouping December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Industrial Products $ 77,423 $ 77,754 $ 240,366 $ 241,595 Crane Solutions 97,541 81,213 266,959 244,791 Engineered Products 21,535 20,693 61,309 62,618 Precision Conveyor Products 33,837 36,382 113,646 104,100 All other 34 46 117 83 Total $ 230,370 $ 216,088 $ 682,397 $ 653,187 Industrial products include: manual chain hoists, electrical chain hoists, rigging/clamps, industrial winches, hooks, shackles, and other forged attachments. Crane solutions products include: wire rope hoists, drives and controls, crane kits and components, and workstations. Engineered products include: linear and mechanical actuators, lifting tables, rail projects, and actuation systems. Precision conveyor products include: low profile, flexible chain, large scale, sanitary and vertical elevation conveyor systems, as well as pallet system conveyors and accumulation systems. The All other product grouping includes miscellaneous revenue. Practical expedients Incremental costs to obtain a contract incurred by the Company primarily relate to sales commissions for contracts with a duration of one year or less. Therefore, these costs are expensed as incurred and are recorded in Selling expenses on the Condensed Consolidated Statements of Operations. Unsatisfied performance obligations for contracts with an expected length of one year or less are not disclosed. Further, revenue from contracts with customers do not include a significant financing component as payment is generally expected within one year from when the performance obligation is controlled by the customer. Accounts Receivable: Under ASU 2016-13, the Company is required to remeasure expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable forecasts. In addition to these factors, the Company establishes an allowance for doubtful accounts based upon the credit risk of specific customers, historical trends, and other factors. Accounts receivable are charged against the allowance for doubtful accounts once all collection efforts have been exhausted. Due to the short-term nature of such accounts receivable, the estimated amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances. The following table illustrates the balance and related activity for the allowance for doubtful accounts that is deducted from accounts receivable to present the net amount expected to be collected in the nine months ended December 31, 2022 and December 31, 2021 (in thousands): Allowance for doubtful accounts December 31, 2022 December 31, 2021 March 31, beginning balance $ 5,717 $ 5,686 Bad debt expense 726 961 Less uncollectible accounts written off, net of recoveries (996) (1,520) Allowance recorded from acquisitions — 227 Other (1) (134) 85 December 31, ending balance $ 5,313 $ 5,439

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	4. Fair Value Measurements FASB ASC Topic 820 “Fair Value Measurements and Disclosures” establishes the standards for reporting financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value on a recurring basis (at least annually). Under these standards, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e. the "exit price") in an orderly transaction between market participants at the measurement date. ASC 820-10-35-37 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the valuation techniques that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is separated into three levels based on the reliability of inputs as follows: Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Level 2 - Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly, involving some degree of judgment. Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The availability of observable inputs can vary and is affected by a wide variety of factors, including the type of asset/liability, whether the asset/liability is established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Fair value is a market-based measure considered from the perspective of a market participant rather than an entity-specific measure. Therefore, even when market assumptions are not readily available, assumptions are required to reflect those that market participants would use in pricing the asset or liability at the measurement date. The Company uses quoted market prices when valuing its marketable securities and, consequently, the fair value is based on Level 1 inputs. These marketable securities consist of equity and fixed income securities. The Company primarily uses readily observable market data in conjunction with internally developed discounted cash flow valuation models when valuing its derivative portfolio and, consequently, the fair value of the Company’s derivatives is based on Level 2 inputs. The carrying amount of the Company's pension-related annuity contract is recorded at net asset value of the contract and, consequently, its fair value is based on Level 2 inputs and is included in Other assets on the Condensed Consolidated Balance Sheets. The carrying value of the Company’s Term Loan approximates fair value based on current market interest rates for debt instruments of similar credit standing and, consequently, their fair values are based on Level 2 inputs. The following table provides information regarding financial assets and liabilities measured or disclosed at fair value (in thousands): Fair value measurements at reporting date using December 31, Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs Description 2022 (Level 1) (Level 2) (Level 3) Assets/(Liabilities) measured at fair value: Marketable securities $ 10,207 $ 10,207 $ — $ — Annuity contract 1,587 — 1,587 — Derivative Assets (Liabilities): Foreign exchange contracts 114 — 114 — Interest rate swap 12,862 — 12,862 — Cross currency swap (1,305) — (1,305) — Disclosed at fair value: Term Loan B $ (467,244) $ — $ (467,244) $ — Fair value measurements at reporting date using March 31, Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs Description 2022 (Level 1) (Level 2) (Level 3) Assets/(Liabilities) measured at fair value: Marketable securities $ 10,294 $ 10,294 $ — $ — Annuity contract 1,884 — 1,884 — Derivative assets (liabilities): Foreign exchange contracts (217) — (217) — Interest rate swap 3,613 — 3,613 — Cross currency swap (8,713) — (8,713) — Disclosed at fair value: Term loan $ (497,534) $ — $ (497,534) $ — The Company does not have any non-financial assets and liabilities that are recognized at fair value on a recurring basis. At December 31, 2022, the Term Loan B has been recorded at carrying value, which approximates fair value. Market gains, interest, and dividend income on marketable securities are recorded in Investment (income) loss on the Condensed Consolidated Statements of Operations. Changes in the fair value of derivatives are recorded in foreign currency exchange (gain) loss or other comprehensive income (loss), to the extent that the derivative qualifies as a hedge under the provisions of FASB ASC Topic 815. Interest and dividend income on marketable securities are measured based upon amounts earned on their respective declaration dates.

Inventories

Inventories	9 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventories	5. Inventories Inventories consisted of the following (in thousands): December 31, March 31, At cost - FIFO basis: Raw materials $ 159,508 $ 129,015 Work-in-process 27,904 28,093 Finished goods 42,371 36,661 Total at cost FIFO basis 229,783 193,769 LIFO cost less than FIFO cost (29,133) (21,630) Net inventories $ 200,650 $ 172,139 An actual valuation of inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations must necessarily be based on management's estimates of expected year-end inventory levels and costs. Because these are subject to many factors beyond management's control, estimated interim results are subject to change in the final year-end LIFO inventory valuation.

Marketable Securities

Marketable Securities	9 Months Ended
	Dec. 31, 2022
Marketable Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure	6. Marketable Securities and Other Investments In accordance with ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities,” all equity investments in unconsolidated entities (other than those accounted for using the equity method of accounting) are measured at fair value through earnings. The Company's marketable securities are recorded at their fair value, with unrealized changes in market value realized within Investment (income) loss on the Condensed Consolidated Statements of Operations. The impact on earnings for unrealized gains and losses was a gain of $362,000 and $145,000 in the three months ended December 31, 2022 and December 31, 2021, respectively, and a loss of $558,000 and a gain of $214,000 in the nine months ended December 31, 2022, and December 31, 2021, respectively. Consistent with prior periods, the estimated fair value is based on quoted market prices at the balance sheet dates. The cost of securities sold is based on the specific identification method. Interest and dividend income are included in Investment (income) loss in the Condensed Consolidated Statements of Operations. Marketable securities are carried as long-term assets since they are held for the settlement of the Company’s general and product liability insurance claims filed through CM Insurance Company, Inc. ("CMIC"), a wholly owned captive insurance subsidiary. The marketable securities are not available for general working capital purposes. Net realized gains related to sales of marketable securities were not material in the three and nine months ended December 31, 2022 and December 31, 2021, respectively.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill Disclosure	7. Goodwill and Intangible Assets Goodwill and indefinite lived trademarks are not amortized but are tested for impairment at least annually, in accordance with the provisions of ASC Topic 350-20-35-1. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. The fair value of a reporting unit is determined using a discounted cash flow methodology. The Company’s reporting units are determined based upon whether discrete financial information is available and reviewed regularly, whether those units constitute a business, and the extent of economic similarities between those reporting units for purposes of aggregation. The Company’s reporting units identified under ASC Topic 350-20-35-33 are at the component level, or one level below the operating segment level as defined under ASC Topic 280-10-50-10 “Segment Reporting - Disclosure.” The Company has three reporting units as of December 31, 2022 and March 31, 2022. The Duff-Norton reporting unit (which designs, manufactures and sources mechanical and electromechanical actuators and rotary unions) had goodwill of $9,699,000 at December 31, 2022 and March 31, 2022. The Rest of Products reporting unit (representing the hoist, chain, forgings, digital power, motion control, manufacturing, and distribution businesses) had goodwill of $304,778,000 and $310,793,000 at December 31, 2022 and March 31, 2022, respectively. The Precision Conveyance reporting unit (which represents high-precision conveying systems) had goodwill of $327,953,000 and $328,357,000 at December 31, 2022 and March 31, 2022, respectively. Refer to the 2022 10-K for information regarding our annual goodwill and indefinite lived trademark impairment evaluation. Future impairment indicators, such as declines in forecasted cash flows, may cause impairment charges. Impairment charges could be based on such factors as the Company’s stock price, forecasted cash flows, assumptions used, control premiums or other variables. There were no such indicators during the three and nine months ended December 31, 2022. A summary of changes in goodwill during the nine months ended December 31, 2022 is as follows (in thousands): Balance at April 1, 2022 $ 648,849 Working capital adjustment for Garvey (Refer to Note 2) 1,616 Garvey contingent payment reclassification (Refer to Note 2) (2,000) Currency translation (6,035) Balance at December 31, 2022 642,430 Goodwill is recognized net of accumulated impairment losses of $113,174,000 as of December 31, 2022 and March 31, 2022, respectively. Identifiable intangible assets acquired in a business combination are amortized over their estimated useful lives. Identifiable intangible assets are summarized as follows (in thousands): December 31, 2022 March 31, 2022 Gross Carrying Accumulated Net Gross Carrying Accumulated Net Trademark $ 19,406 $ (5,926) $ 13,480 $ 19,529 $ (5,032) $ 14,497 Indefinite lived trademark 46,100 — 46,100 46,721 — 46,721 Customer relationships 320,938 (83,427) 237,511 325,431 (71,202) 254,229 Acquired technology 96,339 (26,387) 69,952 96,433 (21,789) 74,644 Other 3,519 (2,903) 616 3,476 (2,779) 697 Total $ 486,302 $ (118,643) $ 367,659 $ 491,590 $ (100,802) $ 390,788 The Company’s intangible assets that are considered to have finite lives are amortized. The weighted-average amortization periods are 14 years for trademarks, 17 years for customer relationships, 16 years for acquired technology, 5 years for other, and 17 years in total. Trademarks with a carrying value of $46,100,000 as of December 31, 2022 have an indefinite useful life and are therefore not being amortized.

Derivative Instruments Derivati

Derivative Instruments Derivative Instruments (Notes)	9 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	8. Derivative Instruments The Company uses derivative instruments to manage selected foreign currency and interest rate exposures. The Company does not use derivative instruments for speculative trading purposes. All derivative instruments must be recorded on the balance sheet at fair value. For derivatives designated as cash flow hedges, changes in the fair value of the derivative is recorded as accumulated other comprehensive loss, or “AOCL,” and is reclassified to earnings when the underlying transaction has an impact on earnings. For foreign currency derivatives not designated as cash flow hedges, all changes in market value are recorded as a foreign currency exchange loss (gain) in the Company’s Consolidated Statements of Operations. The cash flow effects of derivatives are reported within net cash (used for) provided by operating activities on the Condensed Consolidated Statements of Cash Flows. The Company is exposed to credit losses in the event of non-performance by the counterparties on its financial instruments. The counterparties have investment grade credit ratings. The Company anticipates that these counterparties will be able to fully satisfy their obligations under the contracts. The Company's agreements with its counterparties contain provisions pursuant to which the Company could be declared in default of its derivative obligations. As of December 31, 2022, the Company had not posted any collateral related to these agreements. If the Company had breached any of these provisions as of December 31, 2022, it could have been required to settle its obligations under these agreements at amounts which approximate the December 31, 2022 fair values reflected in the table below. During the three and nine months ended December 31, 2022, the Company was not in default of any of its derivative obligations. As of December 31, 2022, the Company had no derivatives designated as net investments or fair value hedges in accordance with FASB ASC Topic 815, “Derivatives and Hedging.” The Company has a cross currency swap agreement that is designated as a cash flow hedge to hedge changes in the value of an intercompany loan to a foreign subsidiary due to changes in foreign exchange rates. This intercompany loan is related to the acquisition of STAHL. As of December 31, 2022, the notional amount of this derivative is $113,041,000, and this contract matures on March 31, 2028. During fiscal 2022, the Company modified the cross currency swap by extending it to fiscal year 2028, matching the intercompany loan. The Company concluded that the transaction to modify the cross currency swap, as well as the modified swap, maintained hedge accounting. The modified cross currency swap is considered to have an other than insignificant financing element. As such, its cash flows are classified within financing activities in the Statement of Cash Flows. From its December 31, 2022 balance of AOCL, the Company expects to reclassify approximately $584,000 out of AOCL, and into foreign currency exchange loss (gain), during the next 12 months based on the contractual payments due under this intercompany loan. The Company has foreign currency forward agreements that are designated as cash flow hedges to hedge a portion of forecasted inventory purchases denominated in foreign currencies. As of December 31, 2022, the notional amount of those derivatives was $4,384,000, and all contracts mature by September 30, 2023. From its December 31, 2022 balance of AOCL, the Company expects to reclassify approximately $51,000 out of AOCL during the next 12 months based on the expected sales of the goods purchased. The Company's policy is to maintain a capital structure that is comprised of 50-70% of fixed rate long term debt and 30-50% of variable rate long term debt. The Company has three interest rate swap agreements in which the Company receives interest at a variable rate and pays interest at a fixed rate. The third interest rate swap agreement was entered into in fiscal year 2022 as a result of the additional debt from the Dorner and Garvey acquisitions. During fiscal 2022, the Company modified the LIBOR floor to match the new Term Loan B resulting from the Dorner related debt refinancing. The Company concluded that the modification maintained hedge accounting. The modified interest rate swap is considered to have an other than insignificant financing element as well as a more than an insignificant initial net investment. As such, its cash flows are classified as financing activities in the Statement of Cash Flows and the swap liability is considered a hybrid debt instrument. These interest rate swap agreements are designated as cash flow hedges to hedge changes in interest expense due to changes in the variable interest rate of the senior secured term loan. The amortizing interest rate swaps mature by February 28, 2025 and had a total notional amount of $280,380,000 as of December 31, 2022. The effective portion of the changes in fair values of the interest rate swaps is reported in AOCL and will be reclassified to interest expense over the life of the swap agreements. As such, its cash flows are classified within financing activities in the Statement of Cash Flows. From its December 31, 2022 balance of AOCL, the Company expects to reclassify approximately $5,860,000 of AOCL, and into interest and debt expense, during the next 12 months. The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the three months ended December 31, 2022 and 2021 (in thousands): Derivatives Designated as Cash Flow Hedges Type of Instrument Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Location of Gain or (Loss) Recognized in Income on Derivatives Amount of Gain or (Loss) Reclassified from AOCL into Income December 31, 2022 Foreign exchange contracts $ 137 Cost of products sold $ (64) December 31, 2022 Interest rate swaps 1,018 Interest expense 1,170 December 31, 2022 Cross currency swaps (6,004) Foreign currency exchange (gain) loss (7,916) December 31, 2021 Foreign exchange contracts (37) Cost of products sold (13) December 31, 2021 Interest rate swap 546 Interest expense (426) December 31, 2021 Cross currency swaps 1,848 Foreign currency exchange (gain) loss 2,386 The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the nine months ended December 31, 2022 and 2021 (in thousands): Derivatives Designated as Cash Flow Hedges Type of Instrument Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Location of Gain or (Loss) Recognized in Income on Derivatives Amount of Gain or (Loss) Reclassified from AOCL into Income December 31, 2022 Foreign exchange contracts $ 89 Cost of products sold $ (153) December 31, 2022 Interest rate swaps 7,423 Interest expense 488 December 31, 2022 Cross currency swaps 5,623 Foreign currency exchange (gain) loss 3,464 December 30, 2021 Foreign exchange contracts (51) Cost of products sold (42) December 30, 2021 Interest rate swap (315) Interest expense (1,220) December 31, 2021 Cross currency swaps 1,358 Foreign currency exchange (gain) loss 4,743 Fair Value of Asset (Liability) Derivatives Designated as Hedging Instruments Balance Sheet Location December 31, 2022 March 31, 2022 Foreign exchange contracts Prepaid expenses and other $ 205 $ — Foreign exchange contracts Accrued liabilities (91) (217) Interest rate swap Prepaid expenses and other 8,268 859 Interest rate swap Other assets 5,193 4,512 Interest rate swap Accrued liabilities (599) (1,371) Interest rate swap Other non current liabilities — (387) Cross currency swap Prepaid expenses and other 495 — Cross currency swap Accrued liabilities — (170) Cross currency swap Other non current liabilities (1,800) (8,543)

Debt

Debt	9 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Debt	9. Debt The Company completed its acquisition of Dorner on April 7, 2021 and entered into a $750,000,000 First Lien Facility with JPMorgan Chase Bank, PNC Capital Markets LLC, and Wells Fargo Securities LLC. The First Lien Facility consists of a New Revolving Credit Facility in an aggregate amount of $100,000,000 and a $650,000,000 Bridge Facility. Proceeds from the Bridge Facility were used, among other things, to finance the purchase price for the Dorner acquisition, pay related fees, expenses and transaction costs, and refinance the Company's outstanding borrowings under its prior Term Loan and Revolver. In addition to the debt borrowing described above, the Company commenced and completed an underwritten public offering of 4,312,500 shares of its common stock at a price of $48.00 per share for total gross proceeds of $207,000,000. The Company used all of the net proceeds from the equity offering to repay in part outstanding borrowings under its Bridge Facility. The equity offering closed on May 4, 2021. Following the repayment of outstanding borrowings under the Bridge Facility, the Bridge Facility was refinanced with a syndicated Term Loan B facility on May 14, 2021. Refer to the 2022 10-K for further details on the Company's Term Loan B facility. In the first nine mo nths of fiscal 2022, the Company incurred $14,803,000 in debt extinguishment costs of which $5,946,000 relates to the Company's prior Term Loan, $326,000 relates to the Company's prior Revolver, and $8,531,000 relates to fees paid on the portion of the First Lien Facilities that were associated with the Bridge Facility, all of which were incurred in the first quarter of fiscal 2022. These costs are classified as Cost of debt refinancing in the Condensed Consolidated Statements of Operations. Further, in the first quarter of fiscal 2022, the Company recorded $5,432,000 in deferred financing costs on the First Lien Term Facility, which is being amortized over seven years. The Company recorded $4,027,000 in deferred financings costs on the New Revolving Credit Facility, of which $3,050,000 is related to the New Revolving Credit Facility and $977,000 is carried over from the Company's prior Revolver as certain Revolver lenders increased their borrowing capacity. These balances will be amortized over five years and are classified in Other assets since no funds were drawn on the New Revolving Credit Facility. Also discussed in Note 2, the Company completed its acquisition of Garvey on November 30, 2021, and borrowed additional funds in accordance with the Accordion feature under its existing Term Loan B facility to increase the principal amount of the Term Loan B facility by $75,000,000. Proceeds from the Accordion were used, among other things, to finance the purchase price for the Garvey acquisition, pay related fees, expenses, and transaction costs. No material amendment to the terms of the Term Loan B facility or the First Lien Facility was necessary for the Company to exercise this Accordion feature. The outstanding principal balance of the Term Loan B facility was $472,560,000 as of December 31, 2022, which includes $75,000,000 in principal balance from the Accordion exercised in the third quarter of fiscal 2022. The Company made $30,000,000 in principal payments on the Term Loan B facility during the nine months ended December 31, 2022 of which $3,945,000 was required. The Company is obligated to make $5,260,000 of principal payments on the Term Loan B facility over the next 12 months plus applicable Excess Cash Flow ("ECF") payments, if required, however, plans to pay down approximately $40,000,000 in principal payments in total during such 12 month period. This amount has been recorded within the current portion of long term debt on the Company's Condensed Consolidated Balance Sheet with the remaining balance recorded as long term debt. There were no outstanding borrowings and $15,937,000 in outstanding letters of credit issued against the New Revolving Credit Facility as of December 31, 2022. The outstanding letters of credit as of December 31, 2022 consisted of $662,000 in commercial letters of credit and $15,275,000 of standby letters of credit. The gross balance of deferred financing costs on the Term Loan B facility was $6,323,000, which includes $892,000 from the Accordion exercise, as of December 31, 2022 and March 31, 2022. The accumulated amortization balances were $1,585,000 and $898,000 as of December 31, 2022 and March 31, 2022, respectively. The gross balance of deferred financing costs associated with the New Revolving Credit Facility is $4,027,000 as of December 31, 2022 and March 31, 2022, respectively, which are included in Other assets on the Condensed Consolidated Balance Sheet. The accumulated amortization balances were $1,409,000 and $805,000 as of December 31, 2022 and March 31, 2022, respectively. The Company has a finance lease for a manufacturing facility in Hartland, WI under a 23 year lease agreement which terminates in 2035. The outstanding balance on the finance lease obligation is $13,683,000 as of December 31, 2022 of which $590,000 has been recorded within the Current portion of long term debt and the remaining balance recorded within Term loan and revolving credit facility on the Company's Condensed Consolidated Balance Sheet. See Note 15 for further details. Unsecured and uncommitted lines of credit are available to meet short-term working capital needs for certain of our subsidiaries operating outside of the U.S. The lines of credit are available on an offering basis, meaning that transactions under the line of credit will be on such terms and conditions, including interest rate, maturity, representations, covenants and events of default, as mutually agreed between our subsidiaries and the local bank at the time of each specific transaction. As of December 31, 2022, unsecured credit lines totaled approximately $2,354,000, of which nothing was drawn. In addition, unsecured lines of $12,762,000 were available for bank guarantees issued in the normal course of business of which $12,524,000 was utilized as of December 31, 2022. Refer to the Company’s consolidated financial statements included in its 2022 10-K for further information on its debt arrangements.

Net Periodic Benefit Cost

Net Periodic Benefit Cost	3 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
Compensation and Employee Benefit Plans	10. Net Periodic Benefit Cost The following table sets forth the components of net periodic pension cost for the Company’s defined benefit pension plans (in thousands): Three Months Ended Nine Months Ended December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Service costs $ 199 $ 242 $ 536 $ 743 Interest cost 2,848 2,528 8,537 7,607 Expected return on plan assets (2,709) (3,259) (8,130) (9,778) Net amortization 192 363 607 1,096 Net periodic pension (benefit) cost $ 530 $ (126) $ 1,550 $ (332) Components of the net benefit costs other than the service cost component are recorded in Other (income) expense, net on the Condensed Consolidated Statements of Operations. Service costs are recorded as part of Income from operations. The Company currently plans to contribute approximately $4,958,000 to its pension plans in fiscal 2023. For additional information on the Company’s defined benefit pension and postretirement benefit plans, refer to the consolidated financial statements included in the 2022 10-K.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	11. Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (in thousands): Three Months Ended Nine Months Ended December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Numerator for basic and diluted earnings per share: Net income (loss) $ 12,029 $ 9,894 $ 34,534 $ 17,834 Denominators: Weighted-average common stock outstanding – denominator for basic EPS 28,626 28,469 28,597 27,887 Effect of dilutive employee stock options and other share-based awards 152 371 170 368 Adjusted weighted-average common stock outstanding and assumed conversions – denominator for diluted EPS 28,778 28,840 28,767 28,255 Stock options with respect to 715,000 and 156,000 common shares for both the three and nine months ended December 31, 2022 and December 31, 2021, respectively, were not included in the computation of diluted income per share because they were antidilutive. For both the three and nine months ended December 31, 2022 and December 31, 2021 contingently issuable common shares of 179,000 and 120,000, respectively, were excluded because a performance condition had not yet been met. The Company grants share based compensation to eligible participants under the 2016 Long Term Incentive Plan, as Amended and Restated in June 2019 ("2016 LTIP"). The total number of shares of common stock with respect to which awards may be granted under the 2016 LTIP were increased by 2,500,000 as a result of the June 2019 amendment and restatement. Shares not previously authorized for issuance under any of the prior stock plans and any shares not issued or subject to outstanding awards under the prior stock plans are still available for issuance. During fiscal 2023, the Company determined that the performance condition on its fiscal 2021 performance shares would not be fully met. The Company has adjusted its stock-based compensation expense accordingly in fiscal 2023. During the quarter ended December 31, 2022, the Company repurchased 31,000 shares of its common stock at an aggregate cost of $1,001,000 in accordance with the Company's previously adopted share repurchase program. The value of the shares purchased are reflected as Treasury stock on the Company's Condensed Consolidated Balance Sheet as of December 31, 2022. During the first nine months of fiscal 2023, there were 32,000 shares of stock issued upon the exercise of stock options that were issued under the Company’s 2016 LTIP. During the fiscal year ended March 31, 2022, 138,000 shares of restricted stock units vested and were issued. In May 2021, the Company issued 4,312,500 shares of common stock raising proceeds of $198,705,000 net of fees in connection with the Dorner acquisition that was completed in April 2021. Additional information regarding this transaction can be found in Note 2 as well as the 2022 10-K. On January 23, 2023, the Company's Board of Directors declared a dividend of $0.07 per common share. The dividend will be paid on February 21, 2023 to shareholders of record on February 10, 2023. The dividend payment is expected to be approximately $2,005,000. Refer to the Company’s consolidated financial statements included in its 2022 10-K for further information on its earnings per share and stock plans.

Loss Contingencies

Loss Contingencies	9 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Loss Contingencies	12. Loss Contingencies From time to time, the Company is named a defendant in legal actions arising out of the normal course of business. The Company is not a party to any pending legal proceeding other than ordinary, routine litigation incidental to our business. The Company does not believe that any of our pending litigation will have a material impact on its business. Accrued general and product liability costs are actuarially estimated reserves based on amounts determined from loss reports, individual cases filed with the Company, and an amount for losses incurred but not reported. The aggregate amounts of reserves were $20,943,000 (gross of estimated insurance recoveries of $8,289,000) as of December 31, 2022, of which $16,043,000 is included in Other non current liabilities and $4,900,000 in Accrued liabilities. The liability for accrued general and product liability costs are funded by investments in marketable securities (see Note 6). The following table provides a reconciliation of the beginning and ending balances for accrued general and product liability: December 31, 2022 March 31, 2022 Accrued general and product liability, beginning of period $ 22,575 $ 21,227 Estimated insurance recoveries (872) 1,109 Add provision for claims 2,050 6,648 Deduct payments for claims (2,810) (6,409) Accrued general and product liability, end of period $ 20,943 $ 22,575 Estimated insurance recoveries (8,289) (9,160) Net accrued general and product liability, end of period $ 12,654 $ 13,415 The per occurrence limits on the self-insurance for general and product liability coverage to Columbus McKinnon through its wholly-owned captive insurance company were $2,000,000 from inception through fiscal 2003 and $3,000,000 for fiscal 2004 and thereafter. In addition to the per occurrence limits, the Company’s coverage is also subject to an annual aggregate limit, applicable to losses only. These limits range from $2,000,000 to $6,000,000 for each policy year from inception through fiscal 2023. The Company also purchases excess general and product liability insurance up to an aggregate $75,000,000 limit. Asbestos Like many industrial manufacturers, the Company is involved in asbestos-related litigation. In continually evaluating costs relating to its estimated asbestos-related liability, the Company reviews, among other things, the incidence of past and recent claims, the historical case dismissal rate, the mix of the claimed illnesses and occupations of the plaintiffs, its recent and historical resolution of the cases, the number of cases pending against it, the status and results of broad-based settlement discussions, and the number of years such activity might continue. Based on this review, the Company has estimated its share of liability to defend and resolve probable asbestos-related personal injury claims. This estimate is highly uncertain due to the limitations of the available data and the difficulty of forecasting with any certainty the numerous variables that can affect the range of the liability. The Company will continue to study the variables in light of additional information in order to identify trends that may become evident and to assess their impact on the range of liability that is probable and estimable. Based on actuarial information, the Company has estimated its net asbestos-related aggregate liability including related legal costs to range between $5,300,000 and $9,700,000, net of insurance recoveries, using actuarial parameters of continued claims for a period of 38 years from December 31, 2022. The Company has estimated its asbestos-related aggregate liability that is probable and estimable, net of insurance recoveries, in accordance with U.S. generally accepted accounting principles approximates $7,067,000. The Company has reflected the liability gross of insurance recoveries of $8,289,000 as a liability in the Condensed Consolidated Balance Sheet as of December 31, 2022. The recorded liability does not consider the impact of any potential favorable federal legislation. This liability will fluctuate based on the uncertainty in the number of future claims that will be filed and the cost to resolve those claims, which may be influenced by a number of factors, including the outcome of the ongoing broad-based settlement negotiations, defensive strategies, and the cost to resolve claims outside the broad-based settlement program. Of this amount, management expects to incur asbestos liability payments of approximately $2,900,000 over the next 12 months. Because payment of the liability is likely to extend over many years, management believes that the potential additional costs for claims will not have a material effect on the financial condition of the Company or its liquidity, although the effect of any future liabilities recorded could be material to earnings in a future period. A share of the Company’s previously incurred asbestos-related expenses and future asbestos-related expenses are covered by pre-existing insurance policies. The Company had been engaged in a legal action against the insurance carriers for those policies to recover past expenses and future costs incurred. The Company came to an agreement with the insurance carriers to settle its case against them for recovery of a portion of past costs and future costs for asbestos-related legal defense costs. The agreement was finalized during the quarter ended September 30, 2020. The terms of the settlement require the carriers to pay gross defense costs prior to retro-premiums of 65% for future asbestos-related defense costs subject to an annual cap of $1,650,000 for claims covered by the settlement. Further, the insurance carriers are expected to cover 100% of indemnity costs related to all covered cases. Estimates of the future cost sharing have been included in the loss reserve calculation as of December 31, 2022 and March 31, 2022. The Company has recorded a receivable for the estimated future cost sharing in Other assets in the Condensed Consolidated Balance Sheet at December 31, 2022 in the amount of $8,289,000, which offsets its asbestos reserves. Product Liability The Company is also involved in other unresolved legal actions that arise in the normal course of business. The most prevalent of these unresolved actions involve disputes related to product design, manufacture and performance liability. The Company's estimation of its product-related aggregate liability that is probable and estimable, in accordance with U.S. generally accepted accounting principles approximates $4,975,000, which has been reflected as a liability in the Condensed Consolidated Balance Sheet as of December 31, 2022. In some cases, the Company cannot reasonably estimate a range of loss because there is insufficient information regarding the matter. Management believes that the potential additional costs for claims will not have a material effect on the financial condition of the Company or its liquidity, although the effect of any future liabilities recorded could be material to earnings in a future period. In addition, one of the Company's subsidiaries, Magnetek, Inc. ("Magnetek"), has been named, along with multiple other defendants, in asbestos-related lawsuits associated with business operations previously acquired but which are no longer owned. During Magnetek's ownership, none of the businesses produced or sold asbestos-containing products. For such claims, Magnetek is uninsured and either contractually indemnified against liability, or contractually obligated to defend and indemnify the purchaser of these former business operations. The Company aggressively seeks dismissal from these proceedings. The asbestos-related liability including legal costs is estimated to be approximately $613,000 which has been reflected as a liability in the Condensed Consolidated Balance Sheet at December 31, 2022. Litigation-Other In October 2010, Magnetek received a request for indemnification from Power-One, Inc. ("Power-One") for an Italian tax matter arising out of the sale of Magnetek's power electronics business to Power-One in October 2006. With a reservation of rights, Magnetek affirmed its obligation to indemnify Power-One for certain pre-closing taxes. The sale included an Italian company, Magnetek, S.p.A., and its wholly owned subsidiary, Magnetek Electronics (Shenzhen) Co. Ltd. (the “Power-One China Subsidiary”). The tax authority in Arezzo, Italy, issued a notice of audit report in September 2010 wherein it asserted that the Power-One China Subsidiary had its administrative headquarters in Italy and, therefore, it should be considered resident in Italy and subject to taxation in Italy. In November 2010, the tax authority issued a notice of tax assessment for the period of July 2003 to June 2004, alleging that taxes of approximately $2,000,000 (Euro 1,900,000), plus interest, were due in Italy on taxable income earned by the Power-One China Subsidiary during this period. In addition, the assessment alleges potential penalties in the amount of approximately $2,400,000 (Euro 2,200,000) for the alleged failure of the Power-One China Subsidiary to file its Italian tax return. The Power-One China Subsidiary filed its response with the provincial tax commission of Arezzo, Italy in January 2011. A hearing before the Tax Court was held in July 2012 on the tax assessment for the period of July 2003 to June 2004. In September 2012, the Tax Court ruled in favor of the Power-One China Subsidiary dismissing the tax assessment for the period of July 2003 to June 2004. In February 2013, the tax authority filed an appeal of the Tax Court's September 2012 ruling. The Regional Tax Commission of Florence heard the appeal of the tax assessment dismissal for the period of July 2003 to June 2004 and thereafter issued its ruling finding in favor of the tax authority. Magnetek believed the court’s decision was based upon erroneous interpretations of the applicable law and appealed the ruling to the Italian Supreme Court in April 2015. In April 2022, the Supreme Court upheld the appeal in favor of Power-One. The tax authority in Arezzo, Italy also issued a tax inspection report in January 2011 for the periods July 2002 to June 2003 (fiscal period 2002/2003) and July 2004 to December 2006 (fiscal periods 2004/2005 and 2005/2006) claiming that the Power-One China Subsidiary failed to file Italian tax returns for the reported periods. In August 2012, the tax authority in Arezzo, Italy issued four notices of tax assessment for the periods July 2002 to June 2003 and July 2004 to December 2006, alleging that taxes of approximately $7,200,000 (Euro 6,700,000) were due in Italy on taxable income earned by the Power-One China Subsidiary together with an allegation of potential penalties in the amount of approximately $3,000,000 (Euro 2,800,000) for the alleged failure of the Power-One China Subsidiary to file its Italian tax returns. On June 3, 2015, the Tax Court, with four judgements, ruled in favor of the Power-One China Subsidiary dismissing the tax assessments for the periods of July 2002 to June 2003 and July 2004 to December 2006. On July 27, 2015, the tax authority filed four appeals of the Tax Court's ruling of June 3, 2015. In May 2016, the Regional Tax Court of Florence rejected the appeals of the tax authority and at the same time canceled the notices of assessment for the fiscal years of 2004/2005 and 2005/2006. The tax authority had up to six months to appeal the decisions. In December 2016, the Power-One China Subsidiary was served by the Italian Revenue Agency with two appeals to the Italian Supreme Court regarding the two positive judgments on the tax assessments for the fiscal periods 2004/2005 and 2005/2006. In February 2017 the Power-One China Subsidiary filed two memorandum before the Italian Supreme Court in response to the appeals made by the tax authority against the positive judgments on the tax assessments for fiscal years 2004/2005 and 2005/2006. In March 2017, the Regional Tax Court of Florence rejected the appeal of the assessment for 2006 fiscal year (period July 2006-December 2006). The tax authority had until October 2017 to appeal this decision. In October 2017, the Power-One China Subsidiary was served by the Italian Revenue Agency with an appeal to the Italian Supreme Court against the positive judgment on the tax assessment for fiscal year 2006. In November 2017 the Power-One China Subsidiary filed a memorandum before the Italian Supreme Court in response to the appeal made by the tax authority against the positive judgment on the tax assessment for fiscal year 2006. In February 2018 an appeal hearing was held at the Regional Tax Court of Florence regarding the Italian tax authority's claim for taxes due for fiscal year 2002/2003. In March 2018, the Regional Tax Court of Florence rejected the appeal of the assessment for 2002/2003 fiscal year. In October 2018 the Power-One China Subsidiary was served by the Italian Revenue Agency with an appeal to the Italian Supreme Court against the positive judgment on the tax assessment for fiscal year 2002/2003. In November 2018 the Power-One China Subsidiary filed a memorandum with the Italian Supreme Court in response to the appeal made by the tax authority. In April 2022, the Supreme Court filed judgments concerning the tax assessments for fiscal years 2002/2003 and 2006. Further, in July 2022, the Supreme Court filed judgments concerning the tax assessments for the fiscal periods 2004/2005 and 2005/2006. In all four judgments, the Supreme Court upheld the appeals of the Italian Tax Authority and remitted the proceedings back to the Regional Tax Court for a new evaluation of the substance of the dispute. In December 2022 the Power One China Subsidiary resumed the proceedings concerning the tax assessments for fiscal years 2002/2003 and 2006 before the Regional Tax Court. The Company believes it will be successful and does not expect to incur a liability related to these assessments. In September of 2017, Magnetek received a request for defense and indemnification from Monsanto Company, Pharmacia, LLC, and Solutia, Inc. (collectively, “Monsanto”) with respect to: (1) lawsuits brought by plaintiffs claiming that Monsanto manufactured polychlorinated biphenyls ("PCBs"), exposure to which allegedly caused injury to plaintiffs; and (2) lawsuits brought by municipalities and municipal entities claiming that Monsanto should be responsible for a variety of damages due to the presence of PCBs in bodies of water in those municipalities and/or in water treated by those municipal entities. Monsanto claims to be entitled to defense and indemnification from Magnetek under a so-called “Special Undertaking” apparently executed by Magnetek’s predecessor Universal Manufacturing ("Universal") in January of 1972, which purportedly required Universal to defend and indemnify Monsanto from liabilities “arising out of or in connection with the receipt, purchase, possession, handling, use, sale or disposition of” PCBs by Universal. Magnetek has declined Monsanto’s tender, and believes that it has meritorious legal and factual defenses to the demands made by Monsanto. Magnetek is vigorously defending against those demands and has commenced litigation in New Jersey to, among other things, declare the Special Undertaking void and unenforceable. Monsanto has, in turn, commenced an action in Missouri seeking to enforce the Special Undertaking. In the Missouri action, Monsanto recently joined five other co-defendants that Monsanto claims are also liable to Monsanto under similar special undertaking agreements. Magnetek intends to continue to vigorously prosecute its New Jersey declaratory judgment action and to defend against Monsanto’s Missouri action. The Company cannot reasonably estimate a potential range of loss with respect to Monsanto’s tender because there is insufficient information regarding the underlying matters. Management believes, however, that the potential additional legal costs related to such matters will not have a material effect on the financial condition of the Company or its liquidity, although the effect of any future liabilities recorded could be material to earnings in a future period. The Company had previously filed suit against Travelers in District Court seeking coverage under insurance policies in the name of Universal. In July 2019, the District Court ruled that Travelers is obligated to defend Magnetek under these policies in connection with Magnetek's litigation against Monsanto. The Court held that Monsanto's claims against Magnetek fall within the insuring agreement of the Travelers policies and that none of the policy exclusions precluded the possibility of coverage. The Court also held that Travelers prior settlements with other insureds under the policies did not cut off or release Magnetek's rights under the policies. Travelers moved for reconsideration and had sought discovery from Magnetek and Monsanto in connection with that motion. On September 22, 2020, the Court issued an order denying the motion to reconsider and denying the motion to compel discovery from Magnetek. The result was that the Court's prior order granting Magnetek partial summary judgment and requiring Travelers' to reimburse Magnetek's defense costs to date and fund its defense and moving forward was now binding, subject to Travelers right to appeal. As a result, the Company received approximately $900,000 for past defense costs which was recorded in fiscal 2021. The Company is also engaged in similar insurance coverage litigation against Transportation Insurance Company in the Circuit Court of Cook County, Illinois. The Company has sought a ruling that Transportation Insurance Company is also obligated to reimburse Magnetek's defense costs to date and fund its defense costs moving forward. That motion is not yet fully briefed. Environmental Matters Along with other manufacturing companies, the Company is subject to various federal, state and local laws relating to the protection of the environment. To address the requirements of such laws, the Company has adopted a corporate environmental protection policy which provides that all of its owned or leased facilities shall, and all of its employees have the duty to, comply with all applicable environmental regulatory standards, and the Company utilizes an environmental auditing program for its facilities to ensure compliance with such regulatory standards. The Company has also established managerial responsibilities and internal communication channels for dealing with environmental compliance issues that may arise in the course of its business. Because of the complexity and changing nature of environmental regulatory standards, it is possible that situations will arise from time to time requiring the Company to incur expenditures in order to ensure environmental regulatory compliance. However, the Company is not aware of any environmental condition or any operation at any of its facilities, either individually or in the aggregate, which would cause expenditures having a material adverse effect on its results of operations, financial condition or cash flows and, accordingly, has not budgeted any material capital expenditures for environmental compliance for fiscal 2023. In 1986, Magnetek acquired the stock of Universal Manufacturing Corporation (“Universal”) from a predecessor of Fruit of the Loom (“FOL”), and the predecessor agreed to indemnify Magnetek against certain environmental liabilities arising from pre-acquisition activities at a facility in Bridgeport, Connecticut. Environmental liabilities covered by the indemnification agreement included completion of additional cleanup activities, if any, at the Bridgeport facility and defense and indemnification against liability for potential response costs related to offsite disposal locations. Magnetek's leasehold interest in the Bridgeport facility was assigned to the buyer in connection with the sale of Magnetek's transformer business in June 2001. FOL, the successor to the indemnification obligation, filed a petition for Reorganization under Chapter 11 of the Bankruptcy Code in 1999 and Magnetek filed a proof of claim in the proceeding for obligations related to the environmental indemnification agreement. Magnetek believes that FOL had substantially completed the clean-up obligations required by the indemnification agreement prior to the bankruptcy filing. In November 2001, Magnetek and FOL entered into an agreement involving the allocation of certain potential tax benefits and Magnetek withdrew its claims in the bankruptcy proceeding. Magnetek further believes that FOL's obligation to the state of Connecticut was not discharged in the reorganization proceeding. In January 2007, the Connecticut Department of Environmental Protection (“DEP”) requested parties, including Magnetek, to submit reports summarizing the investigations and remediation performed to date at the site and the proposed additional investigations and remediation necessary to complete those actions at the site. DEP requested additional information relating to site investigations and remediation. Magnetek and the DEP agreed to the scope of the work plan in November 2010. The Company has recorded a liability of $222,000 included in the amount specified above, related to the Bridgeport facility, representing the best estimate of future site investigation costs and remediation costs which are expected to be incurred in the future. For all of the currently known environmental matters, the Company has accrued as of December 31, 2022 a total of $721,000 which, in our opinion, is sufficient to deal with such matters. The Company is not aware of any environmental condition or any operation at any of its facilities, either individually or in the aggregate, which would cause expenditures to have a material adverse effect on its results of operations, financial condition or cash flows and, accordingly, has not budgeted any material capital expenditures for environmental compliance for fiscal 2023.

Income Taxes

Income Taxes	9 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Tax Disclosure	13. Income Taxes Income tax expense (benefit) as a percentage of income (loss) from continuing operations before income tax expense was 28% and 10% in the three months ended December 31, 2022 and December 31, 2021, respectively and 35% and 13% in the nine months ended December 31, 2022 and December 31, 2021. Typically these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries. During the nine months ended December 31, 2022, the rate was unfavorably impacted 5 percentage points due to settlement of income tax assessments related to tax periods prior to the Company’s acquisition of Stahl Cranesystems GmbH (“STAHL"). In accordance with the tax indemnification clause of the share purchase agreement, the Company received full reimbursement from STAHL’s prior owner which was recorded as a gain in Other (income) expense, net on the Condensed Consolidated Statements of Operations during the period. The tax rate for the nine months ended December 31, 2022 also reflects an unfavorable impact of 4 percentage points due to the recording of a U.S. state tax valuation allowance. The valuation allowance primarily relates to changes in the Company’s expectations regarding its ability to more likely than not utilize certain state net operating losses prior to their expiration. For the three and nine months ended December 31, 2021, the rate was lower than the statutory rate primarily due to benefits generated from carrying a taxable loss back to prior years. The Company estimates that the effective tax rate related to continuing operations will be approximately 30% to 32% for fiscal 2023. Refer to the Company’s consolidated financial statements included in its 2022 10-K for further information on income taxes.

Changes in Other Comprehensive

Changes in Other Comprehensive Loss	9 Months Ended
	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Changes in Other Comprehensive Loss	14. Changes in Accumulated Other Comprehensive Loss Changes in AOCL by component for the three and nine months ended December 31, 2022 are as follows (in thousands): Three months ended December 31, 2022 Retirement Obligations Foreign Currency Change in Derivatives Qualifying as Hedges Total Beginning balance net of tax $ (20,731) $ (47,561) $ 6,598 $ (61,694) Other comprehensive income (loss) before reclassification (338) 12,272 (4,848) 7,086 Amounts reclassified from other comprehensive loss 108 — 6,810 6,918 Net current period other comprehensive income (loss) (230) 12,272 1,962 14,004 Ending balance net of tax $ (20,961) $ (35,289) $ 8,560 $ (47,690) Nine months ended December 31, 2022 Retirement Obligations Foreign Currency Change in Derivatives Qualifying as Hedges Total Beginning balance net of tax $ (21,043) $ (28,079) $ (777) $ (49,899) Other comprehensive income (loss) before reclassification (265) (7,210) 13,136 5,661 Amounts reclassified from other comprehensive loss 347 — (3,799) (3,452) Net current period other comprehensive income (loss) 82 (7,210) 9,337 2,209 Ending balance net of tax $ (20,961) $ (35,289) $ 8,560 $ (47,690) Details of amounts reclassified out of AOCL for the three months ended December 31, 2022 are as follows (in thousands): Details of AOCL Components Amount reclassified from AOCL Affected line item on Condensed Consolidated Statement of Operations Net amortization of prior service cost and pension settlement expense $ 142 142 Total before tax (34) Tax (benefit) expense $ 108 Net of tax Change in derivatives qualifying as hedges $ 83 Cost of products sold (1,525) Interest expense 10,318 Foreign currency 8,876 Total before tax (2,066) Tax (benefit) expense $ 6,810 Net of tax Details of amounts reclassified out of AOCL for the nine months ended December 31, 2022 are as follows (in thousands): Details of AOCL Components Amount reclassified from AOCL Affected line item on Condensed Consolidated Statement of Operations Net amortization of prior service cost and pension settlement expense $ 457 457 Total before tax (110) Tax (benefit) expense $ 347 Net of tax Change in derivatives qualifying as hedges $ 199 Cost of products sold (636) Interest expense (4,515) Foreign currency (4,952) Total before tax 1,153 Tax (benefit) expense $ (3,799) Net of tax These AOCL components are included in the computation of net periodic pension cost. (See Note 10 for additional details.)

Leases Leases (Notes)

Leases Leases (Notes)	9 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Lessee, Operating Leases	15. Leases The Company’s lease arrangements generally include real estate (manufacturing facilities, sales offices, distribution centers, warehouses), vehicles, and equipment. Leases with a term greater than one year are recognized on the Consolidated Balance Sheet; the Company has elected not to recognize leases with terms of one year or less on the Consolidated Balance Sheet. Lease obligations and their corresponding ROU assets are recorded based on the present value of lease payments over the expected lease term. The Company recognizes lease expense on a straight-line basis over the lease term. The Company's leases have lease terms ranging from 1 to 23 years, some of which include options to extend or terminate the lease. The exercise of lease renew all options is at the Company’s sole discretion. When deemed reasonably certain of exercise, the renewal options are included in the determination of the lease term. The Company’s lease agreements do not contain material residual value guarantees or any material restrictive covenants. The following table illustrates the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheet (in thousands): December 31, 2022 March 31, 2022 Operating leases: Other assets $ 32,622 $ 30,809 Accrued liabilities 6,964 7,965 Other non current liabilities 26,574 23,711 Total operating liabilities $ 33,538 $ 31,676 Finance lease: Net property, plant, and equipment $ 12,847 $ 13,525 Current portion of long-term debt and finance lease obligation 590 544 Term loan and finance lease obligations 13,093 13,540 Total finance liabilities $ 13,683 $ 14,084 Operating lease expense of $2,323,000 and $2,332,000 and $6,810,000 and $6,940,000 for the three and nine months ended December 31, 2022 and December 31, 2021, respectively, is included in income from operations on the Condensed Consolidated Statements of Operations. Short-term lease expense, sublease income, and variable lease expenses were not material for the three and nine months ended December 31, 2022 and December 31, 2021, respectively. Finance lease expense of $250,000 for the three months ended December 31, 2022 and December 31, 2021, and $751,000 and $734,000 for the nine months ended December 31, 2022 and December 31, 2021, respectively, is included in Income from operations. Interest and debt expense related to the finance lease of $156,000 and $162,000 and $470,000 and $477,000 is included the Company's Condensed Consolidated Statements of Operations in the three and nine months ended December 31, 2022 and December 31, 2021, respectively. Supplemental cash flow information related to leases is as follows (in thousands): Nine months ended, December 30, 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 6,678 $ 6,885 Cash paid for amounts included in the measurement of finance lease liabilities $ 872 $ 847 ROU assets obtained in exchange for new operating lease liabilities $ 8,592 $ 3,670 ROU assets obtained in exchange for new finance lease liabilities $ — $ 14,582

Effects of New Accounting Prono

Effects of New Accounting Pronouncements	9 Months Ended
	Dec. 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
Effects of New Accounting Pronouncements	16. Effects of New Accounting Pronouncements Topics not yet adopted In December 2022, the FASB issued ASU 2022-06, "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" from December 31, 2022 to December 31, 2024, which is superseding the date from ASU No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." This ASU is elective and is relief to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Optional expedients are provided for contract modification accounting under topics such as debt, leases, and derivatives. The optional amendments are effective for all entities as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through December 31, 2024. We are currently evaluating the impact the standard will have on our consolidated financial statements if we chose to elect. In March 2022, the FASB issued ASU 2022 No. 2022-01, "Derivative and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method." The ASU clarified the guidance in ASC 815 on fair value hedge accounting of interest rate risk for portfolios of financial assets. The ASU amends the guidance in ASU 2017-123 (released on August 28, 2017) that, among other things, established the “portfolio layer” method for making the fair value hedge accounting for these portfolios more accessible. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those years, with early adoption permitted. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. We are currently evaluating the impact the standard will have on our consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers." The ASU amends ASC 805 to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination and is intended to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those years, with early adoption permitted. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. We are currently evaluating the impact the standard will have on our consolidated financial statements.

Business Combinations and Ass_2

Business Combinations and Asset Acquisitions (Tables)	Dec. 01, 2021	Apr. 07, 2021
Dorner
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed		The assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands): Cash $ 8,058 Working Capital 20,218 Property, plant, and equipment, net 26,104 Intangible assets 190,000 Other assets 658 Other liabilities (896) Finance lease liabilities (14,582) Deferred and other taxes, net (35,689) Goodwill 287,141 Total $ 481,012
Garvey
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands): Cash $ 907 Working Capital 1,709 Property, plant, and equipment, net 3,072 Intangible assets 21,350 Other assets 1,382 Other liabilities (1,905) Goodwill 40,832 Total $ 67,347

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Accounts Receivable, Allowance for Credit Loss	The following table illustrates the balance and related activity for the allowance for doubtful accounts that is deducted from accounts receivable to present the net amount expected to be collected in the nine months ended December 31, 2022 and December 31, 2021 (in thousands): Allowance for doubtful accounts December 31, 2022 December 31, 2021 March 31, beginning balance $ 5,717 $ 5,686 Bad debt expense 726 961 Less uncollectible accounts written off, net of recoveries (996) (1,520) Allowance recorded from acquisitions — 227 Other (1) (134) 85 December 31, ending balance $ 5,313 $ 5,439
Disaggregation of Revenue	The following table illustrates the disaggregation of revenue by product grouping for the three and nine months ended December 31, 2022 and December 31, 2021 (in thousands): Three Months Ended Nine Months Ended Net Sales by Product Grouping December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Industrial Products $ 77,423 $ 77,754 $ 240,366 $ 241,595 Crane Solutions 97,541 81,213 266,959 244,791 Engineered Products 21,535 20,693 61,309 62,618 Precision Conveyor Products 33,837 36,382 113,646 104,100 All other 34 46 117 83 Total $ 230,370 $ 216,088 $ 682,397 $ 653,187
Contract with Customer, Contract Asset, Contract Liability, and Receivable	The following table illustrates the balance and related activity for customer advances in the nine months ended December 31, 2022 and December 31, 2021 (in thousands): Customer advances (contract liabilities) December 31, 2022 December 31, 2021 March 31, beginning balance $ 22,453 $ 15,373 Additional customer advances received 56,902 26,807 Revenue recognized from customer advances included in beginning of period (22,453) (15,373) Other revenue recognized from customer advances (34,302) (13,087) Customer advances recorded from acquisitions — 14,750 Other (1) (418) (354) December 31, ending balance $ 22,182 $ 28,116

Fair value Measurements (Tables

Fair value Measurements (Tables)	9 Months Ended
	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis	The following table provides information regarding financial assets and liabilities measured or disclosed at fair value (in thousands): Fair value measurements at reporting date using December 31, Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs Description 2022 (Level 1) (Level 2) (Level 3) Assets/(Liabilities) measured at fair value: Marketable securities $ 10,207 $ 10,207 $ — $ — Annuity contract 1,587 — 1,587 — Derivative Assets (Liabilities): Foreign exchange contracts 114 — 114 — Interest rate swap 12,862 — 12,862 — Cross currency swap (1,305) — (1,305) — Disclosed at fair value: Term Loan B $ (467,244) $ — $ (467,244) $ — Fair value measurements at reporting date using March 31, Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs Description 2022 (Level 1) (Level 2) (Level 3) Assets/(Liabilities) measured at fair value: Marketable securities $ 10,294 $ 10,294 $ — $ — Annuity contract 1,884 — 1,884 — Derivative assets (liabilities): Foreign exchange contracts (217) — (217) — Interest rate swap 3,613 — 3,613 — Cross currency swap (8,713) — (8,713) — Disclosed at fair value: Term loan $ (497,534) $ — $ (497,534) $ —

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consisted of the following (in thousands): December 31, March 31, At cost - FIFO basis: Raw materials $ 159,508 $ 129,015 Work-in-process 27,904 28,093 Finished goods 42,371 36,661 Total at cost FIFO basis 229,783 193,769 LIFO cost less than FIFO cost (29,133) (21,630) Net inventories $ 200,650 $ 172,139

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	A summary of changes in goodwill during the nine months ended December 31, 2022 is as follows (in thousands): Balance at April 1, 2022 $ 648,849 Working capital adjustment for Garvey (Refer to Note 2) 1,616 Garvey contingent payment reclassification (Refer to Note 2) (2,000) Currency translation (6,035) Balance at December 31, 2022 642,430
Schedule of Indefinite-lived Intangible Assets by Major Class	Identifiable intangible assets are summarized as follows (in thousands): December 31, 2022 March 31, 2022 Gross Carrying Accumulated Net Gross Carrying Accumulated Net Trademark $ 19,406 $ (5,926) $ 13,480 $ 19,529 $ (5,032) $ 14,497 Indefinite lived trademark 46,100 — 46,100 46,721 — 46,721 Customer relationships 320,938 (83,427) 237,511 325,431 (71,202) 254,229 Acquired technology 96,339 (26,387) 69,952 96,433 (21,789) 74,644 Other 3,519 (2,903) 616 3,476 (2,779) 697 Total $ 486,302 $ (118,643) $ 367,659 $ 491,590 $ (100,802) $ 390,788

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Tables) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value			The following is information relative to the Company’s derivative instruments in the Condensed Consolidated Balance Sheets (in thousands): Fair Value of Asset (Liability) Derivatives Designated as Hedging Instruments Balance Sheet Location December 31, 2022 March 31, 2022 Foreign exchange contracts Prepaid expenses and other $ 205 $ — Foreign exchange contracts Accrued liabilities (91) (217) Interest rate swap Prepaid expenses and other 8,268 859 Interest rate swap Other assets 5,193 4,512 Interest rate swap Accrued liabilities (599) (1,371) Interest rate swap Other non current liabilities — (387) Cross currency swap Prepaid expenses and other 495 — Cross currency swap Accrued liabilities — (170) Cross currency swap Other non current liabilities (1,800) (8,543)
Derivative Instruments, Gain (Loss)			The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the three months ended December 31, 2022 and 2021 (in thousands): Derivatives Designated as Cash Flow Hedges Type of Instrument Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Location of Gain or (Loss) Recognized in Income on Derivatives Amount of Gain or (Loss) Reclassified from AOCL into Income December 31, 2022 Foreign exchange contracts $ 137 Cost of products sold $ (64) December 31, 2022 Interest rate swaps 1,018 Interest expense 1,170 December 31, 2022 Cross currency swaps (6,004) Foreign currency exchange (gain) loss (7,916) December 31, 2021 Foreign exchange contracts (37) Cost of products sold (13) December 31, 2021 Interest rate swap 546 Interest expense (426) December 31, 2021 Cross currency swaps 1,848 Foreign currency exchange (gain) loss 2,386 The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the nine months ended December 31, 2022 and 2021 (in thousands): Derivatives Designated as Cash Flow Hedges Type of Instrument Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives Location of Gain or (Loss) Recognized in Income on Derivatives Amount of Gain or (Loss) Reclassified from AOCL into Income December 31, 2022 Foreign exchange contracts $ 89 Cost of products sold $ (153) December 31, 2022 Interest rate swaps 7,423 Interest expense 488 December 31, 2022 Cross currency swaps 5,623 Foreign currency exchange (gain) loss 3,464 December 30, 2021 Foreign exchange contracts (51) Cost of products sold (42) December 30, 2021 Interest rate swap (315) Interest expense (1,220) December 31, 2021 Cross currency swaps 1,358 Foreign currency exchange (gain) loss 4,743
Designated as Hedging Instrument | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ (64)	$ (13)	$ (153)	$ (42)
Designated as Hedging Instrument | Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	1,170	(426)	488	(1,220)
Designated as Hedging Instrument | Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ (7,916)	$ 2,386	$ 3,464	$ 4,743

Net Periodic Benefit Cost (Tabl

Net Periodic Benefit Cost (Tables)	9 Months Ended
	Dec. 31, 2022
Pension Plans, Defined Benefiit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Schedule of Net Benefit Costs	The following table sets forth the components of net periodic pension cost for the Company’s defined benefit pension plans (in thousands): Three Months Ended Nine Months Ended December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Service costs $ 199 $ 242 $ 536 $ 743 Interest cost 2,848 2,528 8,537 7,607 Expected return on plan assets (2,709) (3,259) (8,130) (9,778) Net amortization 192 363 607 1,096 Net periodic pension (benefit) cost $ 530 $ (126) $ 1,550 $ (332)

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted earnings per share (in thousands): Three Months Ended Nine Months Ended December 31, 2022 December 31, 2021 December 31, 2022 December 31, 2021 Numerator for basic and diluted earnings per share: Net income (loss) $ 12,029 $ 9,894 $ 34,534 $ 17,834 Denominators: Weighted-average common stock outstanding – denominator for basic EPS 28,626 28,469 28,597 27,887 Effect of dilutive employee stock options and other share-based awards 152 371 170 368 Adjusted weighted-average common stock outstanding and assumed conversions – denominator for diluted EPS 28,778 28,840 28,767 28,255

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	9 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Product Warranty Liability	The following table provides a reconciliation of the beginning and ending balances for accrued general and product liability: December 31, 2022 March 31, 2022 Accrued general and product liability, beginning of period $ 22,575 $ 21,227 Estimated insurance recoveries (872) 1,109 Add provision for claims 2,050 6,648 Deduct payments for claims (2,810) (6,409) Accrued general and product liability, end of period $ 20,943 $ 22,575 Estimated insurance recoveries (8,289) (9,160) Net accrued general and product liability, end of period $ 12,654 $ 13,415

Changes in Other Comprehensiv_2

Changes in Other Comprehensive Loss (Tables)	9 Months Ended
	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Schedule of Accumulated Other Comprehensive Income (Loss)	Changes in AOCL by component for the three and nine months ended December 31, 2022 are as follows (in thousands): Three months ended December 31, 2022 Retirement Obligations Foreign Currency Change in Derivatives Qualifying as Hedges Total Beginning balance net of tax $ (20,731) $ (47,561) $ 6,598 $ (61,694) Other comprehensive income (loss) before reclassification (338) 12,272 (4,848) 7,086 Amounts reclassified from other comprehensive loss 108 — 6,810 6,918 Net current period other comprehensive income (loss) (230) 12,272 1,962 14,004 Ending balance net of tax $ (20,961) $ (35,289) $ 8,560 $ (47,690) Nine months ended December 31, 2022 Retirement Obligations Foreign Currency Change in Derivatives Qualifying as Hedges Total Beginning balance net of tax $ (21,043) $ (28,079) $ (777) $ (49,899) Other comprehensive income (loss) before reclassification (265) (7,210) 13,136 5,661 Amounts reclassified from other comprehensive loss 347 — (3,799) (3,452) Net current period other comprehensive income (loss) 82 (7,210) 9,337 2,209 Ending balance net of tax $ (20,961) $ (35,289) $ 8,560 $ (47,690)
Reclassification out of Accumulated Other Comprehensive Income	etails of amounts reclassified out of AOCL for the three months ended December 31, 2022 are as follows (in thousands): Details of AOCL Components Amount reclassified from AOCL Affected line item on Condensed Consolidated Statement of Operations Net amortization of prior service cost and pension settlement expense $ 142 142 Total before tax (34) Tax (benefit) expense $ 108 Net of tax Change in derivatives qualifying as hedges $ 83 Cost of products sold (1,525) Interest expense 10,318 Foreign currency 8,876 Total before tax (2,066) Tax (benefit) expense $ 6,810 Net of tax Details of amounts reclassified out of AOCL for the nine months ended December 31, 2022 are as follows (in thousands): Details of AOCL Components Amount reclassified from AOCL Affected line item on Condensed Consolidated Statement of Operations Net amortization of prior service cost and pension settlement expense $ 457 457 Total before tax (110) Tax (benefit) expense $ 347 Net of tax Change in derivatives qualifying as hedges $ 199 Cost of products sold (636) Interest expense (4,515) Foreign currency (4,952) Total before tax 1,153 Tax (benefit) expense $ (3,799) Net of tax

Leases (Tables)

Leases (Tables)	3 Months Ended	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2022
Operating Leased Assets [Line Items]
Lease, Cost [Table Text Block]	The following table illustrates the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheet (in thousands): December 31, 2022 March 31, 2022 Operating leases: Other assets $ 32,622 $ 30,809 Accrued liabilities 6,964 7,965 Other non current liabilities 26,574 23,711 Total operating liabilities $ 33,538 $ 31,676 Finance lease: Net property, plant, and equipment $ 12,847 $ 13,525 Current portion of long-term debt and finance lease obligation 590 544 Term loan and finance lease obligations 13,093 13,540 Total finance liabilities $ 13,683 $ 14,084
Schedule of Cash Flow, Supplemental Disclosures	Supplemental cash flow information related to leases is as follows (in thousands): Nine months ended, December 30, 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 6,678 $ 6,885 Cash paid for amounts included in the measurement of finance lease liabilities $ 872 $ 847 ROU assets obtained in exchange for new operating lease liabilities $ 8,592 $ 3,670 ROU assets obtained in exchange for new finance lease liabilities $ — $ 14,582

Description of Business (Narrat

Description of Business (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Revenue from External Customer [Line Items]
Operating Income (Loss)	$ 20,179	$ 15,316	$ 70,372	$ 49,722
Revenue from Contract with Customer Benchmark [Member] | UNITED STATES | Geographic Concentration Risk
Revenue from External Customer [Line Items]
Sales revenue goods net percentage	61%		62%

Acquisitions (Narratives) (Deta

Acquisitions (Narratives) (Details) - USD ($) $ in Thousands				3 Months Ended				9 Months Ended
	Dec. 01, 2021	Nov. 30, 2021	Apr. 07, 2021	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Business Acquisition [Line Items]
Bridge Loan				$ 650,000				$ 650,000
Line of Credit Facility, Maximum Borrowing Capacity				100,000				100,000
Payments to Acquire Businesses, Net of Cash Acquired								$ 1,616	$ 539,778
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life								17 years
Deferred Compensation Arrangement with Individual, Compensation Expense									970
Deferred Compensation Arrangement with Individual, Requisite Service Period							45 days
Revenue from Contract with Customer, Excluding Assessed Tax				230,370		$ 216,088		$ 682,397	653,187
Operating Income (Loss)				20,179		15,316		70,372	49,722
Cost of Goods and Services Sold				148,326		141,031		431,516	422,932
Goodwill				642,430				642,430		$ 648,849
Acquisition Costs, Period Cost						53			8,739
Amortization of Intangible Assets				6,459		6,254		19,442	18,648
Unrealized Gain (Loss) on Investments				362		145		$ 558	214
Cost of Goods and Service, Product and Service Benchmark
Business Acquisition [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense									521
Selling and Marketing Expense [Member]
Business Acquisition [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense									350
General and Administrative Expense [Member]
Business Acquisition [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense									74
Research and Development Expense
Business Acquisition [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense									25
Other
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life								5 years
Technology-Based Intangible Assets [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life								16 years
Customer relationships
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life								17 years
Trademark
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life								14 years
Dorner
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed			The assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands): Cash $ 8,058 Working Capital 20,218 Property, plant, and equipment, net 26,104 Intangible assets 190,000 Other assets 658 Other liabilities (896) Finance lease liabilities (14,582) Deferred and other taxes, net (35,689) Goodwill 287,141 Total $ 481,012
Payments to Acquire Businesses, Net of Cash Acquired			$ 481,012
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			15 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents			$ 8,058
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets			20,218
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			190,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment			26,104
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets			658
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other			(896)
Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation			(14,582)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities			(35,689)
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net			287,141
Revenue from Contract with Customer, Excluding Assessed Tax						31,064			98,781
Operating Income (Loss)						$ 4,157			8,481
Cost of Goods and Services Sold									2,981
Goodwill			287,141
Business Acquisition, Goodwill, Expected Tax Deductible Amount			8,000
Acquisition Costs, Period Cost								$ 0
Severance Costs									$ 218
Dorner | Trade Names
Business Acquisition [Line Items]
Indefinite-lived Intangible Assets Acquired			8,000
Dorner | Technology-Based Intangible Assets [Member]
Business Acquisition [Line Items]
Indefinite-lived Intangible Assets Acquired			45,000
Dorner | Customer relationships
Business Acquisition [Line Items]
Indefinite-lived Intangible Assets Acquired			$ 137,000
Garvey
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands): Cash $ 907 Working Capital 1,709 Property, plant, and equipment, net 3,072 Intangible assets 21,350 Other assets 1,382 Other liabilities (1,905) Goodwill 40,832 Total $ 67,347
Payments to Acquire Businesses, Net of Cash Acquired	$ 67,347
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$ 907
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets	1,709
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	21,350
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	3,072
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	1,382
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	(1,905)
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net	40,832
Acquisition Costs, Period Cost								0
Cash Acquired from Acquisition	907
Debt Instrument, Increase (Decrease), Other, Net		$ 75,000
Business Combination, Contingent Consideration, Liability, Noncurrent	2,000
Payments for (Proceeds from) Previous Acquisition				$ 1,616	$ 1,616			384
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability								$ 1,230
Garvey | Other
Business Acquisition [Line Items]
Finite-Lived Intangible Assets Acquired	330
Garvey | Customer relationships
Business Acquisition [Line Items]
Indefinite-lived Intangible Assets Acquired	8,200
Garvey | Technology Service
Business Acquisition [Line Items]
Finite-Lived Intangible Assets Acquired	4,670
Garvey | Trademark
Business Acquisition [Line Items]
Finite-Lived Intangible Assets Acquired	3,610
Garvey | Patents
Business Acquisition [Line Items]
Finite-Lived Intangible Assets Acquired	2,440
Garvey | Order or Production Backlog
Business Acquisition [Line Items]
Finite-Lived Intangible Assets Acquired	$ 2,100

Revenue Recognition (Details)

Revenue Recognition (Details)	3 Months Ended		9 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)
Contract with Customer, Asset, Net, Current	$ 2,532,000		$ 2,532,000		$ 2,410,000
Revenue from Contract with Customer, Excluding Assessed Tax	230,370,000	$ 216,088,000	682,397,000	$ 653,187,000
Contract with Customer, Liability, Current	22,182,000	28,116,000	22,182,000	28,116,000	22,453,000	$ 15,373,000
Proceeds from Customers for Progress Payments			56,902,000	26,807,000
Contract with Customer, Liability, Revenue Recognized			(22,453,000)	(15,373,000)
Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress			(34,302,000)	(13,087,000)
Revenue, Remaining Performance Obligation, Amount	$ 11,242,000		$ 11,242,000
Revenue, Remaining Performance Obligation, Percentage	36%		36%
Allowance for Doubtful Other Receivables, Current	$ 5,313,000	5,439,000	$ 5,313,000	5,439,000	$ 5,717,000	$ 5,686,000
Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination			0	14,750,000
Contract with Customer, Liability, Other, Foreign Currency Translation			$ (418,000)	(354,000)
Standard Product Contract Terms, Minimum	30		30
Standard Product Contract Terms, Maximum	60		60
Dorner
Revenue from Contract with Customer, Excluding Assessed Tax		31,064,000		98,781,000
SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired			$ 0	227,000
SEC Schedule, 12-09, Allowance, Credit Loss
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense			726,000	961,000
Accounts Receivable, Allowance for Credit Loss, Writeoff			(996,000)	(1,520,000)
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account			(134,000)	(85,000)
Crane Solutions [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 97,541,000	81,213,000	266,959,000	244,791,000
Industrial Products [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	77,423,000	77,754,000	240,366,000	241,595,000
Engineered Products [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	21,535,000	20,693,000	61,309,000	62,618,000
All other [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	34,000	46,000	117,000	83,000
Precision Conveyor Products
Revenue from Contract with Customer, Excluding Assessed Tax	$ 33,837,000	$ 36,382,000	$ 113,646,000	$ 104,100,000
Long-term Contract with Customer [Member]
Revenue, Performance Obligation, Description of Warranty			24 to 36
Short-term Contract with Customer [Member]
Revenue, Performance Obligation, Description of Warranty			12

Fair Value Measurements (Assets

Fair Value Measurements (Assets and liabilities measured at fair value on recurring bases) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Mar. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	$ 10,207	$ 10,294
Marketable securities | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	10,207	10,294
Marketable securities | Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0	0
Marketable securities | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0	0
Variable Annuity [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Annuity contract	1,587	1,884
Variable Annuity [Member] | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Annuity contract	0	0
Variable Annuity [Member] | Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Annuity contract	1,587	1,884
Variable Annuity [Member] | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Annuity contract	0	0
Foreign exchange contracts
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities		(217)
Assets, Fair Value Disclosure	114
Foreign exchange contracts | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities		0
Assets, Fair Value Disclosure	0
Foreign exchange contracts | Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities		(217)
Assets, Fair Value Disclosure	114
Foreign exchange contracts | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities		0
Assets, Fair Value Disclosure	0
Term Loan B
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Term Loan B	(467,244)	(497,534)
Term Loan B | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Term Loan B	0	0
Term Loan B | Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Term Loan B	(467,244)	(497,534)
Term Loan B | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Term Loan B	0	0
Assets [Member] | Interest Rate Swap [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	12,862	3,613
Assets [Member] | Interest Rate Swap [Member] | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure		0
Assets [Member] | Interest Rate Swap [Member] | Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	12,862	3,613
Assets [Member] | Interest Rate Swap [Member] | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure		0
Liability [Member] | Interest Rate Swap [Member] | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	0
Liability [Member] | Interest Rate Swap [Member] | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure	0
Liability [Member] | Cross Currency Interest Rate Contract [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities	(1,305)	(8,713)
Liability [Member] | Cross Currency Interest Rate Contract [Member] | Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities	0	0
Liability [Member] | Cross Currency Interest Rate Contract [Member] | Significant Other Observable Inputs (Level 2)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities	(1,305)	(8,713)
Liability [Member] | Cross Currency Interest Rate Contract [Member] | Significant unobservable Inputs (Level 3)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities	$ 0	$ 0

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Inventory [Line Items]
Raw materials	$ 159,508		$ 129,015
Work-in-process	27,904		28,093
Finished goods	42,371		36,661
At cost - FIFO basis:	229,783		193,769
LIFO cost less than FIFO cost	(29,133)		(21,630)
Inventory, Supplies, Net of Reserves	200,650		$ 172,139
Increase (Decrease) in Inventories	$ 31,701	$ 42,215

Marketable Securities (Narrativ

Marketable Securities (Narratives) (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022	Dec. 21, 2017
Gain (Loss) on Securities [Line Items]
Marketable Securities, Realized Gain (Loss)	$ 0	$ 0	$ 0	$ 0
Unrealized Gain (Loss) on Investments	362,000	145,000	558,000	214,000
Proceeds from Equity Method Investment, Distribution, Return of Capital			313,000	324,000
Equity Method Investments [Member]
Gain (Loss) on Securities [Line Items]
Proceeds from Dividends Received			313,000	324,000
EMC [Member]
Gain (Loss) on Securities [Line Items]
Increase (Decrease) in Accounts Receivable, Related Parties			5,321,000		$ 4,133,000
Equity Method Investments	2,566,000		2,566,000		$ 2,765,000
Investment Income, Net	$ 142,000	$ (218,000)	$ 209,000	$ 157,000
EMC [Member] | EMC [Member]
Gain (Loss) on Securities [Line Items]
Equity Method Investment, Ownership Percentage						49%

Marketable Securities (Summary

Marketable Securities (Summary of available-for-sale securities ) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
EMC [Member]
Debt Securities, Available-for-sale [Line Items]
Investment Income, Net	$ 142,000	$ (218,000)	$ 209,000	$ 157,000

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Narrative) (Details)	3 Months Ended		9 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) Reporting_Unit	Dec. 31, 2021 USD ($)	Mar. 31, 2022 USD ($)
Goodwill [Line Items]
Number of Reporting Units | Reporting_Unit			3
Amortization of intangibles	$ 6,459,000	$ 6,254,000	$ 19,442,000	$ 18,648,000
Goodwill	642,430,000		642,430,000		$ 648,849,000
Finite-Lived Intangible Assets, Amortization Expense, Year Two	25,900,000		25,900,000
Finite-Lived Intangible Assets, Amortization Expense, Year Three	25,900,000		25,900,000
Finite-Lived Intangible Assets, Amortization Expense, Year Four	25,900,000		25,900,000
Finite-Lived Intangible Assets, Amortization Expense, Year Five	25,900,000		$ 25,900,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			17 years
Indefinite-Lived Trademarks	46,100,000		$ 46,100,000		46,721,000
Goodwill, Impaired, Accumulated Impairment Loss	113,174,000		113,174,000		113,174,000
Finite-Lived Intangible Asset, Expected Amortization, Year One	25,900,000		25,900,000
Rest of Products [Member]
Goodwill [Line Items]
Goodwill	304,778,000		304,778,000		310,793,000
Duff Norton Group [Member]
Goodwill [Line Items]
Goodwill	9,699,000		9,699,000		9,699,000
Precision Conveyance
Goodwill [Line Items]
Goodwill	$ 327,953,000		$ 327,953,000		$ 328,357,000
Trademark
Goodwill [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			14 years
Customer relationships
Goodwill [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			17 years
Other Intangible Assets [Member]
Goodwill [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			5 years
Technology-Based Intangible Assets [Member]
Goodwill [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			16 years

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details) - USD ($)	3 Months Ended			9 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022	Dec. 01, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 6,459,000		$ 6,254,000	$ 19,442,000	$ 18,648,000
Goodwill [Roll Forward]
Balance at April 1, 2022				648,849,000
Currency translation				(6,035,000)
Balance at December 31, 2022	642,430,000			642,430,000
Gross Carrying Amount	486,302,000			486,302,000		$ 491,590,000
Accumulated Amortization	(118,643,000)			(118,643,000)		(100,802,000)
Net	367,659,000			367,659,000		390,788,000
Indefinite-Lived Trademarks	46,100,000			46,100,000		46,721,000
Duff Norton Group [Member]
Goodwill [Roll Forward]
Balance at April 1, 2022				9,699,000
Balance at December 31, 2022	9,699,000			9,699,000
Trademark
Goodwill [Roll Forward]
Gross Carrying Amount	19,406,000			19,406,000		19,529,000
Accumulated Amortization	(5,926,000)			(5,926,000)		(5,032,000)
Net	13,480,000			13,480,000		14,497,000
Customer relationships
Goodwill [Roll Forward]
Gross Carrying Amount	320,938,000			320,938,000		325,431,000
Accumulated Amortization	(83,427,000)			(83,427,000)		(71,202,000)
Net	237,511,000			237,511,000		254,229,000
Unpatented Technology [Member]
Goodwill [Roll Forward]
Gross Carrying Amount	96,339,000			96,339,000		96,433,000
Accumulated Amortization	(26,387,000)			(26,387,000)		(21,789,000)
Net	69,952,000			69,952,000		74,644,000
Other
Goodwill [Roll Forward]
Gross Carrying Amount	3,519,000			3,519,000		3,476,000
Accumulated Amortization	(2,903,000)			(2,903,000)		(2,779,000)
Net	616,000			616,000		$ 697,000
Garvey
Goodwill [Roll Forward]
Payments for (Proceeds from) Previous Acquisition	$ 1,616,000	$ 1,616,000		$ 384,000
Business Combination, Contingent Consideration, Liability, Noncurrent							$ (2,000,000)

Derivative Instruments (Narrati

Derivative Instruments (Narratives) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Derivatives, Fair Value [Line Items]
Payments to Acquire Property, Plant, and Equipment			$ 9,511,000	$ 9,506,000
Designated as Hedging Instrument | Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 113,041,000		113,041,000
Derivative Instruments in Hedges, at Fair Value, Net	584,000		584,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(7,916,000)	$ 2,386,000	3,464,000	4,743,000
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)	(6,004,000)	1,848,000	5,623,000	1,358,000
Designated as Hedging Instrument | Cross Currency Interest Rate Contract [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	495,000		495,000		$ 0
Designated as Hedging Instrument | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	4,384,000		4,384,000
Derivative Instruments in Hedges, at Fair Value, Net	51,000		51,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(64,000)	(13,000)	(153,000)	(42,000)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)	137,000	(37,000)	89,000	(51,000)
Designated as Hedging Instrument | Foreign exchange contracts | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	205,000		205,000		0
Designated as Hedging Instrument | Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	280,380,000		280,380,000
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	1,170,000	(426,000)	488,000	(1,220,000)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)	1,018,000	$ 546,000	7,423,000	$ (315,000)
Designated as Hedging Instrument | Interest Rate Swap [Member] | Other Noncurrent Assets
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	5,193,000		5,193,000		4,512,000
Designated as Hedging Instrument | Interest Rate Swap [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	8,268,000		8,268,000		$ 859,000
Designated as Hedging Instrument | Reclassify Next Year [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments in Hedges, at Fair Value, Net	$ 5,860,000		$ 5,860,000
Maximum [Member]
Derivatives, Fair Value [Line Items]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	50%		50%
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	70%		70%
Minimum [Member]
Derivatives, Fair Value [Line Items]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	30%		30%
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	50%		50%

Derivative Instruments (Derivat

Derivative Instruments (Derivative instruments in the condensed consolidated balance sheet) (Details) - Designated as Hedging Instrument - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ (64)	$ (13)	$ (153)	$ (42)
Foreign exchange contracts | Accrued liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	(91)		(91)		$ (217)
Foreign exchange contracts | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	205		205		0
Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	1,170	(426)	488	(1,220)
Interest Rate Swap [Member] | Accrued liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	(599)		(599)		(1,371)
Interest Rate Swap [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	8,268		8,268		859
Interest Rate Swap [Member] | Other Noncurrent Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0		0		(387)
Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(7,916)	$ 2,386	3,464	$ 4,743
Cross Currency Interest Rate Contract [Member] | Accrued liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0		0		(170)
Cross Currency Interest Rate Contract [Member] | Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	495		495		0
Cross Currency Interest Rate Contract [Member] | Other Noncurrent Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	$ (1,800)		$ (1,800)		$ (8,543)

Debt (Narratives) (Details)

Debt (Narratives) (Details) - USD ($)			3 Months Ended		9 Months Ended
	Nov. 30, 2021	May 04, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-term Debt			$ 750,000,000		$ 750,000,000
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			100,000,000		100,000,000
Outstanding borrowings			472,560,000		472,560,000
Current portion of long term debt and finance lease obligations			40,596,000		40,596,000		$ 40,551,000
Deferred Costs			6,323,000		6,323,000
Accumulated Amortization, Deferred Finance Costs			1,585,000		1,585,000		898,000
Unsecured credit lines			$ 2,354,000		2,354,000
Amount drawn on unsecured credit lines					0
Stock Issued During Period, Shares, New Issues		4,312,500				4,312,500
Common Stock, Par or Stated Value Per Share		$ 48
Proceeds from Issuance or Sale of Equity					$ 0	$ 207,000,000
Lessee, Finance Lease, Term of Contract			23 years		23 years
Operating Income (Loss)			$ 20,179,000	$ 15,316,000	$ 70,372,000	49,722,000
Long-term Debt			750,000,000		750,000,000
Short-term Debt			40,000,000		40,000,000
Debt Instrument, Periodic Payment, Principal			30,000,000
Debt Instrument, Periodic Payment			3,945,000
Bridge Loan			650,000,000		650,000,000
Gain (Loss) on Extinguishment of Debt			0	0	0	14,803,000
Amortization of Intangible Assets			6,459,000	6,254,000	19,442,000	18,648,000
Acquisition Costs, Period Cost				53,000		8,739,000
Dorner
Line of Credit Facility [Line Items]
Operating Income (Loss)				4,157,000		8,481,000
Debt Issuance Costs, Gross				4,027,000		4,027,000
Acquisition Costs, Period Cost					0
Garvey
Line of Credit Facility [Line Items]
Debt Instrument, Increase (Decrease), Other, Net	$ 75,000,000
Acquisition Costs, Period Cost					0
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Accumulated Amortization, Deferred Finance Costs			1,409,000		1,409,000		805,000
Extinguishment of Debt, Amount						326,000
Revolving Credit Facility [Member] | Dorner
Line of Credit Facility [Line Items]
Debt Issuance Costs, Gross				977,000		977,000
Required payments [Member]
Line of Credit Facility [Line Items]
Current portion of long term debt and finance lease obligations			5,260,000		5,260,000
Secured Debt
Line of Credit Facility [Line Items]
Debt Issuance Costs, Gross				5,432,000		5,432,000
Secured Debt | Loans [Member]
Line of Credit Facility [Line Items]
Debt Issuance Costs, Gross			892,000		892,000
Bridge Loan
Line of Credit Facility [Line Items]
Extinguishment of Debt, Amount						8,531,000
New Revolving Credit Facility
Line of Credit Facility [Line Items]
Outstanding letters of credit			15,937,000		15,937,000
Other Deferred Costs, Gross			4,027,000		4,027,000		$ 4,027,000
New Revolving Credit Facility | Dorner
Line of Credit Facility [Line Items]
Debt Issuance Costs, Gross				$ 3,050,000		3,050,000
New Revolving Credit Facility | Standby Letters of Credit
Line of Credit Facility [Line Items]
Outstanding letters of credit			15,275,000		15,275,000
New Revolving Credit Facility | Letter of Credit
Line of Credit Facility [Line Items]
Outstanding letters of credit			662,000		662,000
New Revolving Credit Facility | Unsecured Lines of Credit
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			12,762,000		12,762,000
Outstanding borrowings			$ 12,524,000		$ 12,524,000
Long-Term Debt
Line of Credit Facility [Line Items]
Extinguishment of Debt, Amount						$ 5,946,000

Net Periodic Benefit Cost (Narr

Net Periodic Benefit Cost (Narratives) (Details) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Effect of dilutive employee stock options and other share-based awards	152	371	170	368
Average basic shares outstanding	28,626	28,469	28,597	27,887
Share-based Payment Arrangement, Option [Member]
Defined Benefit Plan Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			715	156
Pension Plans, Defined Benefiit
Defined Benefit Plan Disclosure [Line Items]
Service costs	$ 199,000	$ 242,000	$ 536,000	$ 743,000
Interest cost	2,848,000	2,528,000	8,537,000	7,607,000
Defined Benefit Plan, Expected Return (Loss) on Plan Assets	(2,709,000)	(3,259,000)	(8,130,000)	(9,778,000)
Net amortization	192,000	363,000	607,000	1,096,000
Net periodic pension (benefit) cost	$ 530,000	$ (126,000)	$ 1,550,000	$ (332,000)
Forecast [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year					$ 4,958,000

Net Periodic Benefit Cost (Comp

Net Periodic Benefit Cost (Components of net periodic pension cost and net periodic postretirement benefit cost) (Details) - Pension Plans, Defined Benefiit - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Service costs	$ 199	$ 242	$ 536	$ 743
Interest cost	2,848	2,528	8,537	7,607
Expected return on plan assets	(2,709)	(3,259)	(8,130)	(9,778)
Net amortization	192	363	607	1,096
Net periodic pension (benefit) cost	$ 530	$ (126)	$ 1,550	$ (332)

Earnings Per Share (Narratives)

Earnings Per Share (Narratives) (Details) - USD ($)				3 Months Ended						9 Months Ended		12 Months Ended
	Feb. 21, 2023	Jan. 23, 2023	May 04, 2021	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment				152,000			371,000			170,000	368,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period										32,000
Common Stock, Dividends, Per Share, Declared				$ 0.07			$ 0.06			$ 0.14	$ 0.12
Proceeds from Other Equity									$ 198,705,000		$ 198,705,000
Stock Issued During Period, Shares, New Issues			4,312,500								4,312,500
Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares										179,000	120,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				3,258	9,531	18,907	47,292	38,744	12,682			138,000
Average basic shares outstanding				28,626,000			28,469,000			28,597,000	27,887,000
Treasury Stock, Value				$ 1,001,000						$ 1,001,000		$ 0
Treasury Stock, Shares				31,085						31,085
Treasury Stock, Common, Shares				31,000						31,000
2016 LTIP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of shares of common stock available for grant				2,500,000						2,500,000
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount										715,000	156,000
Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Dividends, Per Share, Declared		$ 0.07
Dividends	$ 2,005,000

Earnings Per Share (Computation

Earnings Per Share (Computation of basic and diluted earnings per share) (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended					9 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Numerator for basic and diluted earnings per share:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 12,029	$ 14,114	$ 9,894	$ 15,203	$ (7,263)	$ 34,534	$ 17,834
Denominators:
Average basic shares outstanding	28,626		28,469			28,597	27,887
Effect of dilutive employee stock options and other share-based awards	152		371			170	368
Average diluted shares outstanding	28,778		28,840			28,767	28,255
Share-based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount						715	156

Loss Contingencies (Narratives)

Loss Contingencies (Narratives) (Details)			6 Months Ended	9 Months Ended			12 Months Ended
	Aug. 02, 2012 USD ($)	Aug. 02, 2012 EUR (€)	Sep. 30, 2022 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) Rate	Dec. 31, 2022 EUR (€)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)
Loss Contingencies [Line Items]
Loss Contingency Accrual							$ 22,575,000	$ 21,227,000
Insurance Recoveries					$ 872,000		1,109,000
Loss Contingency Accrual, Product Liability, Gross					20,943,000		22,575,000
Estimation of asbestos-related aggregate liability that is probable and estimable					7,067,000
Estimation of product-related aggregate liability					4,975,000
Loss Contingency Alleged Taxes Owed	$ 7,200,000	€ 6,700,000			2,000,000	€ 1,900,000
Loss Contingency Alleged Taxes Owed Including Penalties And Interest	$ 3,000,000	€ 2,800,000			2,400,000	€ 2,200,000
Accrual for Environmental Loss Contingencies					721,000
Loss Contingency Accrual, Provision					2,050,000		6,648,000
Loss Contingency Accrual, Payments					(2,810,000)		(6,409,000)
Estimated Insurance Recoveries					(8,289,000)		(9,160,000)
Loss Contingency Accrual, Product Liability, Net					$ 12,654,000		$ 13,415,000
Financial Guarantee Insurance Contracts, Risk Management Activities, Mitigating Claim Liabilities, Policy					75,000,000	75,000,000
Per Occurrence Limits on Self Insurance for General and Product Liability Coverage from inception through FY 2003					$ 2,000,000
Per Occurrence Limits on Self Insurance for General and Product Liability Coverage from FY 2004 through current FY					$ 3,000,000
Indemnity Costs Covered by Insurance, Percentage | Rate					100%
Gross Defense Costs Prior to Retro Premiums Required by Settlement, Percentage | Rate					65%
Minimum [Member]
Loss Contingencies [Line Items]
Product Liability Contingency, Third Party Recovery					$ 2,000,000
Loss contingency period					38 years	38 years
Estimation of asbestos-related aggregate liability that is probable and estimable					$ 5,300,000
Maximum [Member]
Loss Contingencies [Line Items]
Product Liability Contingency, Third Party Recovery					6,000,000
Estimation of asbestos-related aggregate liability that is probable and estimable					9,700,000
Litigation Settlement, Amount Awarded from Other Party					1,650,000
Magnetek [Member]
Loss Contingencies [Line Items]
Estimation of asbestos-related aggregate liability that is probable and estimable					613,000
Other Noncurrent Liabilities [Member]
Loss Contingencies [Line Items]
Loss Contingency Accrual					16,043,000
Accrued Liabilities
Loss Contingencies [Line Items]
Loss Contingency Accrual, Product Liability, Gross					4,900,000
Forecast [Member]
Loss Contingencies [Line Items]
Asbestos liability payments				$ 2,900,000
Loss settlement gross period				12 months
DEP [Member] | Magnetek [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies					$ 222,000
Travelers
Loss Contingencies [Line Items]
Increase (Decrease) in Insurance Settlements Receivable			$ 900,000

Income Taxes (Narratives) (Deta

Income Taxes (Narratives) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021
Income tax expense as a percentage of income from continuing operations			21%
Effective Income Tax Rate Reconciliation, Percent	28%	10%	35%	13%
Effective Income Tax Rate Reconciliation, Tax Settlement, Percent			5%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent			4%
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (47,690)	$ (66,574)	$ (47,690)	$ (66,574)		$ (61,694)		$ (49,899)	$ (64,920)	$ (57,911)	$ (59,986)
AOCI Attributable to Parent
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (47,690)		$ (47,690)			$ (61,694)	$ (55,765)	$ (49,899)
Forecast [Member] | Minimum [Member]
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent					30%
Forecast [Member] | Maximum [Member]
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent					32%

Changes in Other Comprehensiv_3

Changes in Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Dec. 31, 2022	Dec. 31, 2022
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Beginning balance net of tax	$ (61,694)	$ (49,899)
Other comprehensive income (loss) before reclassification	7,086	5,661
Amounts reclassified from other comprehensive loss	6,918	(3,452)
Net current period other comprehensive income (loss)	14,004	2,209
Ending balance net of tax	(47,690)	(47,690)
AOCI Attributable to Parent
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Beginning balance net of tax	(61,694)	(49,899)
Ending balance net of tax	(47,690)	(47,690)
Retirement Obligations
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Beginning balance net of tax	(20,731)	(21,043)
Other comprehensive income (loss) before reclassification	(338)	(265)
Amounts reclassified from other comprehensive loss	108	347
Net current period other comprehensive income (loss)	(230)	82
Ending balance net of tax	(20,961)	(20,961)
Foreign currency exchange (gain) loss
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Beginning balance net of tax	(47,561)	(28,079)
Other comprehensive income (loss) before reclassification	12,272	(7,210)
Amounts reclassified from other comprehensive loss	0	0
Net current period other comprehensive income (loss)	12,272	(7,210)
Ending balance net of tax	(35,289)	(35,289)
Change in Derivatives Qualifying as Hedges
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	8,876	(4,952)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax	6,810	(3,799)
Gain (Loss) on Derivative Instruments
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Beginning balance net of tax	6,598	(777)
Other comprehensive income (loss) before reclassification	(4,848)	13,136
Amounts reclassified from other comprehensive loss	6,810	(3,799)
Net current period other comprehensive income (loss)	1,962	9,337
Ending balance net of tax	8,560	8,560
Tax expense | Retirement Obligations
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	(34)	(110)
Tax expense | Change in Derivatives Qualifying as Hedges
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	(2,066)	1,153
Cost of products sold | Retirement Obligations
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	142	457
Cost of products sold | Change in Derivatives Qualifying as Hedges
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	83	199
Interest Expense [Member] | Change in Derivatives Qualifying as Hedges
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	(1,525)	(636)
Foreign currency exchange (gain) loss | Change in Derivatives Qualifying as Hedges
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Amounts reclassified from other comprehensive loss	$ 10,318	$ (4,515)

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			$ 8,592	$ 3,670
Operating Lease, Payments			6,678	6,885
Short-term Lease, Cost			0	0
Sublease Income			0	0
Variable Lease, Cost			0	0
Operating Leased Assets [Line Items]
Operating Lease, Payments			6,678	6,885
Finance Lease, Principal Payments			872	847
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			8,592	3,670
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability			0	14,582
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	$ 12,847		12,847		$ 13,525
Finance Lease, Liability, Current	590		590		544
Finance Lease, Liability, Noncurrent	13,093		13,093		13,540
Finance Lease, Liability	13,683		13,683		14,084
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	32,622		32,622		30,809
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	6,964		6,964		7,965
Operating Lease, Liability, Noncurrent	26,574		26,574		23,711
Operating Lease, Liability	$ 33,538		33,538		$ 31,676
Lessee, Lease, Description [Line Items]
Finance Lease, Principal Payments			872	847
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			8,592	3,670
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability			0	14,582
Operating Lease, Payments			$ 6,678	6,885
Lessee, Operating Lease, Term of Contract	1 year		1 year
Lessee, Finance Lease, Term of Contract	23 years		23 years
Operating Lease, Cost	$ 2,323	$ 2,332	$ 6,810	6,940
Operating Income (Loss)
Lessee, Lease, Description [Line Items]
Lease, Cost	250	250	751	734
Interest Expense [Member]
Lessee, Lease, Description [Line Items]
Lease, Cost	$ 156	$ 162	$ 470	$ 477

Subsequent Events (Details)

Subsequent Events (Details)	Feb. 21, 2023 USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividends	$ 2,005,000

Uncategorized Items - cmco-2022

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 202,377,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 115,640,000